2022 Project Z Numbers
To view by category, hover over the title of the category and select the up or down arrow to sort by that column.
To search on the page click "control F" or "command F" to bring up the search box.
Lab/Branch | PI Name | Z Number | Project Title |
---|---|---|---|
Laboratory of Pathology | Abdullaev, Zied | ZID BC 012090 | Classification of tumors using whole-genome methylation profiling |
Cancer and Developmental Biology Laboratory | Acharya, Jairaj | ZIA BC 010331 | Phospholipid and Sphingolipid Signaling in Drosophila |
Cancer and Developmental Biology Laboratory | Acharya, Jairaj | ZIA BC 011187 | Sphingolipid Signaling in Mammals |
Laboratory of Molecular Biology | Adhya, Sankar | ZIA BC 008751 | Regulation of Gene Transcription |
Laboratory of Molecular Biology | Adhya, Sankar | ZIA BC 010017 | Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases |
Developmental Therapeutics Branch | Aladjem, Mirit | ZIA BC 010411 | Initiation of DNA Replication in Mammalian Cells |
Laboratory of Pathology | Aldape, Kenneth | ZIA BC 011846 | Single-cell DNA methylation analysis of human cancer |
Laboratory of Pathology | Aldape, Kenneth | ZIA BC 011847 | Development and validation of a predictor of meningioma recurrence |
Laboratory of Pathology | Aldape, Kenneth | ZIA BC 011850 | Genomic Biomarkers of Cancer |
Laboratory of Molecular Biology | Alewine, Christine | ZIA BC 011652 | Mesothelin-targeted immunotoxins in Pancreatic Cancer |
Laboratory of Molecular Biology | Alewine, Christine | ZIA BC 011886 | First in Human Trials of ProAgio, a Cytotoxin |
Laboratory of Molecular Biology | Alewine, Christine | ZIA BC 012041 | Rare Exocrine Tumors of the Pancreas |
Laboratory of Molecular Biology | Alewine, Christine | ZIE BC 011653 | Clinical Support |
Laboratory of Integrative Cancer Immunology | Altan-Bonnet, Gregoire | ZIA BC 011726 | Phenotypic variability within isogenic population of lymphocytes |
Laboratory of Integrative Cancer Immunology | Altan-Bonnet, Gregoire | ZIA BC 011728 | Cytokine coordination of collective immune responses against tumors |
Laboratory of Integrative Cancer Immunology | Altan-Bonnet, Gregoire | ZIA BC 011781 | Dynamics of hematopoietic differentiation |
Laboratory of Integrative Cancer Immunology | Altan-Bonnet, Gregoire | ZIA BC 011807 | Immunophenotyping by CyTOF and machine learning |
Laboratory of Integrative Cancer Immunology | Altan-Bonnet, Gregoire | ZIA BC 012007 | Dynamics of viral infection |
Laboratory of Human Carcinogenesis | Ambs, Stefan | ZIA BC 010499 | Maryland Prostate Cancer Case-Control Study |
Laboratory of Human Carcinogenesis | Ambs, Stefan | ZIA BC 010624 | The Molecular Profile of Prostate Tumors in African-American Men |
Laboratory of Human Carcinogenesis | Ambs, Stefan | ZIA BC 010887 | Novel Markers for Disease Outcome in Breast Cancer |
Laboratory of Cell Biology | Ambudkar, Suresh | ZIA BC 010030 | Biochemical Analysis of Multidrug Resistance-linked Transport Proteins |
Cancer Innovation Laboratory | Anderson, Stephen | ZIA BC 010013 | Molecular Studies of Cellular Cytotoxicity |
Women's Malignancies Branch | Annunziata, Christina | ZIA BC 011054 | Nuclear Factor-kappaB in Ovarian Cancer |
Women's Malignancies Branch | Annunziata, Christina | ZIA BC 011584 | Clinical trials in womens cancers |
Women's Malignancies Branch | Annunziata, Christina | ZIA BC 011775 | Immune cell control of ovarian cancer |
Genetics Branch | Aplan, Peter | ZIA BC 010982 | Collaborative Pathways that Lead to Leukemia |
Genetics Branch | Aplan, Peter | ZIA BC 010983 | Pre-clinical Studies of Therapy for Myelodysplastic Syndrome |
Genetics Branch | Aplan, Peter | ZIA SC 010378 | Activation of Proto-Oncogenes by Chromosomal Translocation |
Genetics Branch | Aplan, Peter | ZIA SC 010379 | Mechanisms of Chromosomal Translocation |
Genitourinary Malignancies Branch | Apolo, Andrea | ZIA BC 011351 | Bladder Cancer Program |
Genitourinary Malignancies Branch | Apolo, Andrea | ZIA BC 011594 | Targeting the MET Pathway in Urothelial Carcinoma |
Genitourinary Malignancies Branch | Apolo, Andrea | ZIA BC 011928 | Rare genitourinary tumors projects |
Laboratory of Cell Biology | Appella, Ettore | ZIA BC 005599 | Tumor Suppressor Protein, p53 |
Laboratory of Cell Biology | Appella, Ettore | ZIA BC 011197 | Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells |
Laboratory of Receptor Biology and Gene Expression | Arda, Hatice | ZIA BC 011798 | Identification of genomic regulatory elements in pancreas cells |
Molecular Targets Program | Aregger, Michael | ZIA BC 012099 | Genetic interaction screening in renal cell carcinoma |
Molecular Targets Program | Aregger, Michael | ZIA BC 012100 | Combinatorial CRISPR transcriptional perturbation screening platform |
Molecular Targets Program | Aregger, Michael | ZIA BC 012101 | Establishing combinatorial screening platform coupled to single-cell analysis |
Molecular Targets Program | Aregger, Michael | ZIA BC 012102 | Improving editing efficiency and guide design of CHyMErA screening platform |
Neuro-Oncology Branch | Armstrong, Terri | ZIA BC 011768 | Natural History and Specimen Banking for Patients with CNS Tumors |
Neuro-Oncology Branch | Armstrong, Terri | ZIA BC 011837 | Outcomes and Risk of Rare Tumors |
Neuro-Oncology Branch | Armstrong, Terri | ZIA BC 011893 | Behavioral Correlates in Mouse Model of CNS radiation-induced hypersomnia |
Neuro-Oncology Branch | Armstrong, Terri | ZIA BC 012073 | Implementation of telehealth and health technology to improve patient outcomes |
OCD-OD Admin | Armstrong, Terri | ZIA BC 012078 | Office of Patient-Centered Outcomes Research (OPCORe) |
Laboratory of Immune Cell Biology | Ashwell, Jonathan | ZIA BC 011264 | Glucocorticoids and T cell development and function |
Laboratory of Immune Cell Biology | Ashwell, Jonathan | ZIA BC 011715 | T cell receptor proximal signaling |
Laboratory of Immune Cell Biology | Ashwell, Jonathan | ZIA BC 011976 | TNF and inflammation |
Laboratory of Biochemistry and Molecular Biology | Bai, Yawen | ZIA BC 010808 | Chromatin structure and dynamics |
Genitourinary Malignancies Branch | Banday, Abdul | ZIA BC 012091 | Investigating mechanisms of bladder tumorigenesis |
Chemical Biology Laboratory | Barchi, Joseph | ZIA BC 010451 | Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy |
Chemical Biology Laboratory | Barchi, Joseph | ZIA BC 011232 | A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead |
Laboratory of Pathology | Barr, Frederic | ZIA BC 011378 | Studies of amplification in rhabdomyosarcoma |
Laboratory of Pathology | Barr, Frederic | ZIA BC 011387 | Studies of gene fusions in rhabdomyosarcoma |
Laboratory of Pathology | Barr, Frederic | ZIA BC 011423 | Epigenetic studies in rhabdomyosarcoma |
Laboratory of Pathology | Barr, Frederic | ZIE BC 011384 | Anatomic Pathology Residency Program |
Genetics Branch | Basrai, Munira | ZIA BC 010822 | Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation |
Laboratory of Cell Biology | Batista, Pedro | ZIA BC 011766 | Regulation of RNA biogenesis and function by RNA modifications |
Vaccine Branch | Berzofsky, Jay | ZIA BC 011941 | Studies of the SARS-CoV-2 Spike Protein |
Vaccine Branch | Berzofsky, Jay | ZIA BC 012054 | Vaccine strategies for HIV/AIDS |
Vaccine Branch | Berzofsky, Jay | ZIA SC 004020 | Vaccine and immunotherapy strategies for cancer and viruses causing cancer |
Molecular Targets Program | Beutler, John | ZIA BC 011469 | Building Libraries with Chemical Diversity for Screening |
Molecular Targets Program | Beutler, John | ZIA BC 011470 | Development of Natural Product Leads as Anticancer Therapeutics |
Surgery Branch | Beyer, Rachel | ZIC BC 010989 | Clinical production of viral vectors for cancer gene therapy |
Surgery Branch | Beyer, Rachel | ZIC BC 012049 | QC and Release Testing of Clinical Vector and Cell Gene Therapy Products |
Surgery Branch | Beyer, Rachel | ZIC BC 012051 | Use of lentivirus in individualized cell-gene therapy |
Laboratory of Genome Integrity | Bhandoola, Avinash | ZIA BC 011633 | T cell Development and Regeneration |
Surgical Oncology Program | Blakely, Andrew | ZIE BC 012097 | Surgical Oncology Program Training Program |
Laboratory of Immune Cell Biology | Bosselut, Remy | ZIA BC 010671 | Genetic Analysis of T-cell Differentiation |
Laboratory of Genome Integrity | Boxer, Lisa | ZIA BC 012110 | Chromatin Regulation in Brain Development and Disease |
Laboratory of Cell and Developmental Signaling | Brognard, John | ZIA BC 011690 | Novel Tumor Suppressing Kinases in Cancer |
Laboratory of Cell and Developmental Signaling | Brognard, John | ZIA BC 011691 | Oncogenic Kinases in Cancer |
Office of the Director | Bronez, Melissa | ZIJ BC 011285 | CCR Education and Outreach |
Laboratory of Cellular Oncology | Buck, Christopher | ZIA BC 011090 | Molecular biology of human polyomaviruses |
Laboratory of Cellular Oncology | Buck, Christopher | ZIA BC 011460 | BKV and JCV vaccine development |
Laboratory of Human Carcinogenesis | Budhu, Anuradha | ZIA BC 011870 | Liver Cancer Program |
Chemical Biology Laboratory | Burke, Terrence | ZIA BC 006198 | Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents |
Chemical Biology Laboratory | Burke, Terrence | ZIA BC 007363 | Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs |
Basic Research Laboratory Bethesda | Bustin, Michael | ZIA BC 004496 | Chromosomal Proteins and Chromosomal Functions |
Basic Research Laboratory Bethesda | Bustin, Michael | ZIA BC 011154 | Biological Functions of Chromosomal Proteins |
Center for Structural Biology | Byrd, R. Andrew | ZIA BC 011131 | Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway |
Center for Structural Biology | Byrd, R. Andrew | ZIA BC 011132 | Methods Development |
Center for Structural Biology | Byrd, R. Andrew | ZIA BC 011419 | Structural Biology of GTPase Activating Proteins |
Genetics Branch | Calzone, Kathy | ZIC BC 011931 | Genomic Data Sharing |
Genetics Branch | Calzone, Kathy | ZID BC 011908 | Clinical Cancer Genomics Program |
Genetics Branch | Calzone, Kathy | ZIE BC 011912 | Genomic Competency Initiative |
Radiation Oncology Branch | Camphausen, Kevin | ZIA SC 010372 | Pre-clinical Development of Radiation Sensitizers for Patients with Glioblastoma |
Radiation Oncology Branch | Camphausen, Kevin | ZIA SC 010373 | The Synergy Between Radiotherapy and Molecularly Targeted Agents |
Radiation Oncology Branch (OOC) | Camphausen, Kevin | ZIC BC 010991 | Radiation Oncology Branch - Microarray Facility |
Radiation Oncology Branch (OOC) | Camphausen, Kevin | ZID BC 010990 | Radiation Oncology Branch - Radiation Clinic |
Genetics Branch | Cao, Liang | ZIC BC 010981 | Biomarker Investigations for Clinical Trials |
Genetics Branch | Cao, Liang | ZIC BC 012031 | Omics Technology facility |
Genetics Branch | Caplen, Natasha | ZIA BC 011704 | Discovery of genes required for expression or activity of fusion oncogenes |
Laboratory of Cancer Biology and Genetics | Cappell, Steven | ZIA BC 011830 | Control of cell cycle commitment by APC-C-Cdh1 |
Laboratory of Cancer Biology and Genetics | Cappell, Steven | ZIA BC 011832 | Study cell cycle regulation in dormant tumor cells |
Cancer Innovation Laboratory | Carrell, Jeffrey | ZIC BC 011236 | CCR-Frederick Flow Cytometry Core |
Laboratory of Integrative Cancer Immunology | Carrington, Mary | ZIA BC 010791 | Effects of genetic polymorphism in MHC, KIR, and related loci on human disease |
Laboratory of Integrative Cancer Immunology | Carrington, Mary | ZIA BC 010792 | Molecular genetics and population studies of the KIR and HLA gene complexes |
Laboratory of Integrative Cancer Immunology | Carrington, Mary | ZIA BC 011949 | Host genetic resistance to COVID-19 |
Laboratory of Biochemistry and Molecular Biology | Chen, Chongyi | ZIA BC 011884 | The dynamics of chromatin topology in human cells |
Thoracic Surgery Branch | Chen, Haobin | ZIA BC 011787 | Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer |
Thoracic Surgery Branch | Chen, Haobin | ZIA BC 011839 | Developing an Effective BET bromodomain inhibitor Drug Combo to Target SCLC |
Laboratory of Molecular Biology | Cheng, Sheue-yann | ZIA BC 008752 | Thyroid Hormone Nuclear Receptors in Health and Disease |
Laboratory of Molecular Biology | Cheng, Sheue-yann | ZIA BC 011191 | Preclinical Mouse Models of Thyroid Cancer |
Radiation Biology Branch | Cherukuri, Murali | ZIA BC 010476 | Time Domian Electron Paramagnetic Resonance Imaging |
Radiation Biology Branch | Cherukuri, Murali | ZIA BC 010477 | Overhauser Enhanced Magnetic Resonance Imaging (OMRI) |
Laboratory of Pathology | Chinquee, Joseph | ZIC BC 010687 | Histology Core Laboratory |
Laboratory of Pathology | Chinquee, Joseph | ZIC BC 011731 | Tissue Procurement, Processing Facility and Biorepository |
Laboratory of Pathology | Chinquee, Joseph | ZID BC 010686 | Clinical Operations for Laboratory of Pathology |
Molecular Imaging Branch | Choyke, Peter | ZIA BC 010655 | Prostate Cancer Imaging |
Molecular Imaging Branch | Choyke, Peter | ZIA BC 010656 | Growth Factor Imaging and Photoimmunotherapy |
Molecular Imaging Branch | Choyke, Peter | ZIA BC 010657 | Cellular In vivo Imaging |
Molecular Imaging Branch | Choyke, Peter | ZIA BC 010668 | Instrumentation for microSPECT and microPET imaging |
Office of the Director | Choyke, Peter | ZIA BC 011872 | PSMA-PET Imaging of High Risk Prostate Cancer-Cures |
Radiation Oncology Branch | Citrin, Deborah | ZIA BC 010850 | Mechanisms of Normal Tissue Toxicity From Irradiation |
Radiation Oncology Branch | Citrin, Deborah | ZIA BC 011552 | Targeting mechanisms of radiation resistance |
Radiation Oncology Branch | Coleman, C. Norman | ZIA BC 010670 | Radiation-induced molecular targets |
HIV Dynamics and Replication Program | Compton, Alex | ZIA BC 011756 | An Intrinsic Link between the Metabolic and Antiviral States of the Cell |
HIV Dynamics and Replication Program | Compton, Alex | ZIA BC 011779 | Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry |
HIV Dynamics and Replication Program | Compton, Alex | ZIA BC 011967 | Deciphering the Double-Edged Role of IFITM3 during SARS-CoV-2 Infection |
Genetics Branch | Conner, Elizabeth | ZIC BC 011623 | CCR Genomics Core |
Urologic Oncology Branch | Crooks, Daniel | ZIC BC 011932 | Metabolomics Core |
Office of the Director | Custer, Mary | ZIG BC 010856 | Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research |
Cancer and Developmental Biology Laboratory | Daar, Ira | ZIA BC 010006 | Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways |
Cancer and Developmental Biology Laboratory | Daar, Ira | ZIA BC 010958 | Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion |
Genitourinary Malignancies Branch | Dahut, William | ZIA SC 010098 | The Evaluation of Novel Therapeutics for Genitourinary Malignancies |
Mouse Cancer Genetics Program | Dai, Chengkai | ZIA BC 011767 | Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1 |
Laboratory of Receptor Biology and Gene Expression | Dalal, Yamini | ZIA BC 011206 | Role of histone variants in aging and cancer |
Laboratory of Receptor Biology and Gene Expression | Dalal, Yamini | ZIA BC 011207 | Biomechanical properties of chromatin in cancer and normal cells |
Laboratory of Receptor Biology and Gene Expression | Dalal, Yamini | ZIA BC 011209 | Formation of Centromeres in vivo |
Surgery Branch | Danforth, David | ZIA SC 006663 | Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer |
Cancer and Developmental Biology Laboratory | Davies, Erin | ZIA BC 012009 | Mechanisms underlying establishment of regeneration competence |
Cancer and Developmental Biology Laboratory | Davies, Erin | ZIA BC 012055 | Anatomical and gene expression resource for Macrostomum lignano |
Cancer and Developmental Biology Laboratory | Davies, Erin | ZIA BC 012119 | Inductive germ cell specification and self-assembly of sexually dimorphic gonads |
Cancer and Developmental Biology Laboratory | Davies, Erin | ZIA BC 012120 | Adult pluripotent stem cell specification during planarian embryogenesis |
Developmental Therapeutics Branch | Doroshow, James | ZIA BC 010677 | NADPH Oxidases as Novel Targets for Cancer Therapy |
Developmental Therapeutics Branch | Doroshow, James | ZIA BC 011078 | Phase 0-1 Clinical Trials |
Molecular Targets Program | Du, Lin | ZIA BC 011568 | Natural Products Discovery and Characterization Through Network Collaborations |
Laboratory of Cancer Biology and Genetics | DuBois, Wendy | ZIC BC 011047 | Animal Model and Genotyping Core Support Facility |
Laboratory of Cell Biology | Durell, Stewart | ZIA BC 011379 | Inhibitor Development Against the Wip1 Phosphatase |
Laboratory of Cell Biology | Durell, Stewart | ZIA BC 012084 | Modeling Oligomeric Structures of Amyloid forming Peptides |
Laboratory of Cell Biology | Durell, Stewart | ZIA BC 012085 | Computer Simulation Studies of Solvation Thermodynamics |
Laboratory of Cell Biology | Durell, Stewart | ZIC BC 011075 | Molecular Modeling of the Human P-glycoprotein Transporter Protein |
Laboratory of Cell Biology | Durell, Stewart | ZIC BC 011077 | Molecular Modeling of Interactions Regulating the Activity of the p53 Protein |
Laboratory of Cell Biology | Durell, Stewart | ZIC BC 011380 | HIV NCp7 inhibitors and Multivalent Inhibition of Membrane Receptors |
Laboratory of Cell Biology | Durell, Stewart | ZIC BC 011724 | Effects of Cytosine Modifications on Transcription Factor Binding |
Cancer Innovation Laboratory | Durum, Scott | ZIA BC 009287 | Cytokines and T Cell Development |
Cancer Innovation Laboratory | Durum, Scott | ZIA BC 011150 | Chronic Inflammation and Carcinogenesis |
Center for Structural Biology | Elmlund, Hans | ZIA BC 012087 | Unsupervised image processing methods for cryoEM analysis in real time |
Center for Structural Biology | Elmlund, Hans | ZIA BC 012088 | Algorithms for atomic-resolution structure identification of nanocrystals |
Molecular Imaging Branch | Escorcia, Freddy | ZIA BC 011800 | Engineering HCC-selective PET agent |
Vaccine Branch | Felber, Barbara | ZIA BC 010334 | Conserved Element DNA Vaccine |
Vaccine Branch | Felber, Barbara | ZIA BC 010350 | Development & testing of nucleic acid-based vaccine for HIV & other indications |
Vaccine Branch | Felber, Barbara | ZIA BC 011940 | COVID-19 vaccine in naive individuals and cancer patients |
Vaccine Branch | Felber, Barbara | ZIA BC 012105 | Examining IL-15 as an immunotherapy agent in cancer and AIDS |
Genitourinary Malignancies Branch | Figg, William | ZIA BC 010453 | Genetics and Molecular Mechanisms of Prostate Cancer |
Genitourinary Malignancies Branch | Figg, William | ZIA BC 010547 | Drug Development for Prostate Cancer and other Metastatic Processes |
Office of the Clinical Director | Figg, William | ZIA BC 010627 | Clinical Pharmacogenetics |
Office of the Clinical Director | Figg, William | ZIA BC 011996 | Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy |
Genitourinary Malignancies Branch | Figg, William | ZIA SC 006538 | Development of Anticancer Agents |
Office of the Clinical Director | Figg, William | ZIC SC 006536 | Biospecimen Processing and Biorepository |
Office of the Clinical Director | Figg, William | ZIC SC 006537 | Using Clinical Pharmacology Principles to Develop New Anticancer Therapies |
Laboratory of Pathology | Filie, Armando | ZIC BC 011052 | Cytopathology Core |
Laboratory of Molecular Biology | FitzGerald, David | ZIA BC 008757 | Bio-Therapies for the Treatment of Cancer |
Laboratory of Pathology | Flomerfelt, Francis | ZIC BC 010934 | Immune reconstitution following autologous and allogeneic stem cell transplant |
Laboratory of Pathology | Flomerfelt, Francis | ZIC BC 011029 | Preclinical development and clinical monitoring of adoptive immune therapy |
Vaccine Branch | Franchini, Genoveffa | ZIA BC 005645 | Role of the HTLV-1A and HTLV1-C inflammatory profile in disease |
Vaccine Branch | Franchini, Genoveffa | ZIA BC 011126 | Development of rationally designed HIV vaccines |
Vaccine Branch | Franchini, Genoveffa | ZIA BC 012025 | Phase I HIV vaccine trial with DNA/ALVAC-HIV gp120 delta V1 vaccines |
HIV Dynamics and Replication Program | Freed, Eric | ZIA BC 010778 | HIV-1 Maturation |
HIV Dynamics and Replication Program | Freed, Eric | ZIA BC 011720 | Gag Trafficking, Assembly, and Release |
HIV Dynamics and Replication Program | Freed, Eric | ZIA BC 011721 | Envelope Glycoprotein Incorporation and Function |
HIV Dynamics and Replication Program | Freed, Eric | ZIA BC 011968 | Antagonism of Coronavirus Spike Proteins by Cellular Host Factors |
Neuro-Oncology Branch | Gilbert, Mark | ZIA BC 011640 | Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas |
Neuro-Oncology Branch | Gilbert, Mark | ZIA BC 011643 | Rare Central Nervous System Cancers Initiative |
Neuro-Oncology Branch | Gilbert, Mark | ZIA BC 011647 | Identifying New Glioma-Associated Tumor Suppressors and Oncogenes |
Neuro-Oncology Branch | Gilbert, Mark | ZIA BC 011714 | Translational Immunology |
Neuro-Oncology Branch | Gilbert, Mark | ZIA BC 011784 | Bioinformatics: Characterizing Brain Tumor Data |
Office of the Director | Gilbert, Mark | ZIA BC 011853 | CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures |
Neuro-Oncology Branch | Gilbert, Mark | ZIC BC 011641 | Pre-clinical Translational Research Facility |
Neuro-Oncology Branch | Gilbert, Mark | ZID BC 011642 | Brain Tumor Clinical and Clinical Research Program |
Chemical Biology Laboratory | Gildersleeve, Jeffrey | ZIA BC 010675 | Development of a Carbohydrate Microarray |
Chemical Biology Laboratory | Gildersleeve, Jeffrey | ZIA BC 010740 | Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins |
Chemical Biology Laboratory | Gildersleeve, Jeffrey | ZIA BC 011055 | Serum Antibody Profiling with a Carbohydrate Microarray |
Pediatric Oncology Branch | Glod, John | ZIA BC 012072 | Early Detection of Cancer Patients with Germline SDH Deficiency |
Pediatric Oncology Branch | Glod, John | ZID BC 011517 | Pediatric Oncology Branch Behavioral Science Core |
Pediatric Oncology Branch | Glod, John | ZIE BC 011516 | Pediatric Oncology Branch Clinical Care and Education |
Office of Science and Technology Resources | Goldstein, David | ZIC BC 011331 | CCR Sequencing Facility |
Office of the Director | Goldstein, David | ZIC BC 011532 | CCR Collaborative Bioinformatics Resource |
Office of Science and Technology Resources | Goldstein, David | ZIK BC 010857 | Science and Technology Resources |
Laboratory of Integrative Cancer Immunology | Goldszmid, Romina | ZIA BC 011670 | Role of the microbiota in regulating the mononuclear phagocyte system |
RNA Biology Laboratory | Gonatopoulos Pournatzis, Thomas | ZIA BC 012019 | Investigating the regulation of alternative splicing and its role in disease |
RNA Biology Laboratory | Gonatopoulos Pournatzis, Thomas | ZIA BC 012033 | High-throughput phenotypic screening for functionally characterizing alt. exons |
Cancer Innovation Laboratory | Gonzalez, Frank | ZIA BC 005562 | Xenobiotic receptors |
Cancer Innovation Laboratory | Gonzalez, Frank | ZIA BC 005708 | Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers |
Laboratory of Cell Biology | Gottesman, Michael | ZIA BC 005598 | Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells |
Laboratory of Cell Biology | Gottesman, Michael | ZIA BC 010830 | Mechanisms of non-classical multidrug resistance in cancer |
Laboratory of Cell Biology | Gottesman, Michael | ZIA BC 012052 | Zebrafish model of blood-brain barrier to improve drug delivery to the brain |
Laboratory of Molecular Biology | Gottesman, Susan | ZIA BC 008714 | Bacterial Functions Involved in Cell Growth Control |
Laboratory of Molecular Biology | Gottesman, Susan | ZIA BC 011203 | Proteolysis and Regulation of Bacterial Cell Growth Control |
Experimental Transplantation and Immunotherapy Branch | Gress, Ronald | ZIA BC 010525 | Immune Reconstitution |
Experimental Transplantation and Immunotherapy Branch | Gress, Ronald | ZIA BC 010960 | ETIB Clinical Trials |
Experimental Transplantation and Immunotherapy Branch | Gress, Ronald | ZID BC 010963 | ETIB Clinical Research Core |
Thoracic and GI Malignancies Branch | Greten, Tim | ZIA BC 011343 | Clinical protocols for the treatment of gastrointestinal cancer |
Thoracic and GI Malignancies Branch | Greten, Tim | ZIA BC 011344 | Immune suppressor mechanisms in patients with GI cancer |
Thoracic and GI Malignancies Branch | Greten, Tim | ZIA BC 011345 | Analysis of cancer-related immune suppressor mechanisms in mice |
Office of the Director | Greten, Tim | ZIA BC 011855 | Center for Cell-based Therapy - Cures |
Laboratory of Biochemistry and Molecular Biology | Grewal, Shiv | ZIA BC 010523 | RNAi and Epigenetic Control of Higher-Order Chromatin Assembly |
Laboratory of Biochemistry and Molecular Biology | Grewal, Shiv | ZIA BC 011208 | Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome |
RNA Biology Laboratory | Gu, Shuo | ZIA BC 011566 | Mechanism, Regulation and Application of miRNA pathway in cancer |
Center for Immuno-Oncology | Gulley, James | ZIA BC 010666 | Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines |
Center for Immuno-Oncology | Gulley, James | ZIA BC 010945 | Clinical trials employing cancer vaccine combination therapies |
Office of the Director | Gulley, James | ZIA BC 011871 | T-Cell Receptor Gene Therapy for Human Cancers-Cures |
Center for Immuno-Oncology | Gulley, James | ZIA BC 012067 | Cellular Therapy |
Laboratory of Receptor Biology and Gene Expression | Hager, Gordon | ZIA BC 005450 | Chromatin Structure and Gene Expression |
Laboratory of Receptor Biology and Gene Expression | Hager, Gordon | ZIA BC 010027 | Function of Steroid Receptors in Subcellular Compartments |
Laboratory of Receptor Biology and Gene Expression | Hager, Gordon | ZIA BC 010308 | In vivo Imaging Analysis of Steroid-Nuclear Receptor Function |
Surgery Branch | Halas, Hyunmi | ZIC BC 010905 | Surgery Branch Cell Prep Core |
Surgery Branch | Halas, Hyunmi | ZIC BC 011569 | Cell Production Core Facility |
Cancer Data Science Laboratory | Hannenhalli, Sridhar | ZIA BC 011964 | Transcriptomic origins of cancer |
Cancer Data Science Laboratory | Hannenhalli, Sridhar | ZIA BC 011978 | Developmental origins of cancer |
Cancer Data Science Laboratory | Hannenhalli, Sridhar | ZIA BC 011979 | Identifying non-coding drivers of cancer |
Cancer Data Science Laboratory | Hannenhalli, Sridhar | ZIA BC 011981 | Machine learning, network-based models for gene expression, activity, function |
Cancer Data Science Laboratory | Hannenhalli, Sridhar | ZIA BC 011984 | Gene interactions in cancer |
Laboratory of Human Carcinogenesis | Harris, Curtis | ZIA BC 011492 | Precision Medicine of Cancer |
Laboratory of Human Carcinogenesis | Harris, Curtis | ZIA BC 011496 | p53, Aging, and Cancer |
Thoracic and GI Malignancies Branch | Hassan, Raffit | ZIA BC 010816 | Immunotherapy for Malignant Mesothelioma and Lung Cancer |
Thoracic and GI Malignancies Branch | Hassan, Raffit | ZID BC 011540 | Thoracic and Gastrointestinal Malignancies Branch Clinical Core |
Office of the Director | Henderson, Darren | ZII BC 011234 | CCR New Space Activation |
Surgical Oncology Program | Hernandez, Jonathan | ZIA BC 011759 | Interrogating the molecular underpinnings of metastatic colonization |
Surgical Oncology Program | Hernandez, Jonathan | ZIA BC 011861 | Evaluating outcomes for patients with primary-metastatic gastrointestinal cancer |
Pediatric Oncology Branch | Heske, Christine | ZIA BC 011745 | Development of biologic based therapies for rhabdomyosarcoma |
Pediatric Oncology Branch | Heske, Christine | ZIA BC 011774 | Development and translation of novel therapies for pediatric sarcoma |
Laboratory of Pathology | Hewitt, Stephen | ZIC BC 011638 | Experimental Pathology Laboratory (EPL) |
Immune Deficiency and Cellular Therapy Program | Hickstein, Dennis | ZIA BC 010870 | Hematopoietic Stem Cell Transplant for GATA2 Deficiency |
Immune Deficiency and Cellular Therapy Program | Hickstein, Dennis | ZIA BC 011994 | Allogeneic Hematopoietic Transplantation for Primary Immunodeficiency Diseases |
Immune Deficiency and Cellular Therapy Program | Hickstein, Dennis | ZIA BC 012075 | Hematopoietic Stem Cell Transplant for VEXAS |
Immune Deficiency and Cellular Therapy Program | Hickstein, Dennis | ZIA SC 010384 | Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency |
Laboratory of Molecular Biology | Ho, Mitchell | ZIA BC 010891 | Development of new antibody-based cancer therapies |
Laboratory of Molecular Biology | Ho, Mitchell | ZIA BC 011943 | Development of neutralizing nanobodies against SARS-CoV-2 |
Laboratory of Molecular Biology | Ho, Mitchell | ZIC BC 011891 | Antibody Engineering Program |
Thoracic Surgery Branch | Hoang, Chuong | ZIA BC 011657 | microRNA-based and novel molecular therapeutics in thoracic cancers |
Experimental Immunology Branch | Hodes, Richard | ZIA BC 009265 | Analysis of the T Cell Repertoire |
Experimental Immunology Branch | Hodes, Richard | ZIA BC 009281 | Receptor Mediated T and B Cell Activation |
Experimental Immunology Branch | Hodes, Richard | ZIA BC 009405 | Regulation of Lymphocyte Proliferation and Replicative Capacity |
Center for Immuno-Oncology | Hodge, James | ZIA BC 010661 | Vaccine and Drug Combination Therapy for Human Cancers |
Center for Immuno-Oncology | Hodge, James | ZIA BC 010975 | Vaccine and radiation for the therapy of human cancers |
HIV Dynamics and Replication Program | Hu, Wei-Shau | ZIA BC 010504 | Understanding Retroviral Reverse Transcription, Recombination, and Replication |
HIV Dynamics and Replication Program | Hu, Wei-Shau | ZIA BC 010506 | Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly |
HIV Dynamics and Replication Program | Hu, Wei-Shau | ZIA BC 010814 | Elucidating the Regulation of HIV RNA Functions: Translation & Genome Packaging |
HIV Dynamics and Replication Program | Hu, Wei-Shau | ZIA BC 011969 | Development of Cell-based Assays to Identify SARS-CoV-2 Protease Inhibitor |
Cancer Innovation Laboratory | Hu, Yinling | ZIA BC 011212 | Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis |
Cancer Innovation Laboratory | Hu, Yinling | ZIA BC 011391 | Role of IKK alpha in lung cancer development |
Cancer Innovation Laboratory | Hu, Yinling | ZIA BC 011422 | Role of IKK alpha in lymphoid organ development |
Laboratory of Cancer Biology and Genetics | Huang, Jing | ZIA BC 011158 | Stress responses in embryonic stem cells |
Laboratory of Cancer Biology and Genetics | Huang, Jing | ZIA BC 011504 | Vulnerabilities in osteosarcoma and breast cancer |
HIV Dynamics and Replication Program | Hughes, Stephen | ZIA BC 010481 | HIV-1 Reverse Transcriptase |
HIV Dynamics and Replication Program | Hughes, Stephen | ZIA BC 011426 | HIV-1 Integrase |
Laboratory of Cancer Biology and Genetics | Hunter, Kent | ZIA BC 011255 | Genetic Modifiers of Initiation and Progression of Mammary Cancer |
Laboratory of Human Carcinogenesis | Hussain, S. Perwez | ZIA BC 011162 | Integrative Molecular Profiling of Human Pancreatic Cancer |
Laboratory of Human Carcinogenesis | Hussain, S. Perwez | ZIA BC 011185 | Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer |
Laboratory of Cellular and Molecular Biology | Iglesias-Bartolome, Ramiro | ZIA BC 011763 | Signaling pathways regulating stem cell fate decisions |
Laboratory of Cellular and Molecular Biology | Iglesias-Bartolome, Ramiro | ZIA BC 011764 | G-protein-coupled receptor signaling in cancer development and treatment |
Center for Immuno-Oncology | Ishii, Kazusa | ZIA BC 012045 | TCR engineered T cell therapies for hematologic malignancies |
Laboratory of Pathology | Jaffe, Elaine | ZIA BC 011070 | Hematopathology Diagnosis |
Laboratory of Pathology | Jaffe, Elaine | ZIA SC 000550 | Lymphoma Disease Discovery and Definition |
Laboratory of Pathology | Jaffe, Elaine | ZIE BC 011241 | Hematopathology Fellowship |
Laboratory of Cell Biology | Jenkins, Lisa | ZIC BC 011430 | CPTR - Mass Spectrometry Unit |
Center for Structural Biology | Ji, Xinhua | ZIA BC 010326 | Biomolecular Structure and Mechanism, Structure-Based Drug Design |
Cancer Data Science Laboratory | Jiang, Peng | ZIA BC 011889 | Data-driven inference of regulators for cytokine-mediated tumor killing |
Cancer Data Science Laboratory | Jiang, Peng | ZIA BC 011890 | Computational approaches for the analyses of spatial profiling technologies |
Mouse Cancer Genetics Program | Johnson, Peter | ZIA BC 012098 | Control of Oncogenic Signaling Through Spatial Organization of Kinases and mRNAs |
Laboratory of Pathology | Jones, Jennifer | ZIA BC 011502 | Biophysical Characterization of EVPs and other Macromolecular Nanoparticles |
Laboratory of Pathology | Jones, Jennifer | ZIA BC 011503 | Discovery of Tumor, Treatment Response, and Systems-based EVP Signatures |
Laboratory of Pathology | Jones, Jennifer | ZIA BC 011942 | Translational Nanobiology Approaches to Viral Diseases (HIV, HTLV, SARS-CoV2) |
Laboratory of Pathology | Jones, Jennifer | ZIA BC 012107 | Classification and Ontology of Macromolecular Complexes in Liquid Biopsies |
Center for Immuno-Oncology | Kanakry, Christopher | ZIA BC 011659 | Deciphering the efficacy of posttransplant cyclophosphamide in BMT |
Center for Immuno-Oncology | Kanakry, Jennifer | ZIA BC 012065 | Reduced toxicity allogeneic hematopoietic cell transplantation in malignancies |
Office of the Clinical Director | Kanakry, Jennifer | ZIE BC 010843 | NIH Hematology Oncology Fellowship Program |
Pediatric Oncology Branch | Kaplan, Rosandra | ZIA BC 011332 | Tumor Microenvironment in Cancer Progression |
Pediatric Oncology Branch | Kaplan, Rosandra | ZIA BC 011334 | Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis |
Laboratory of Receptor Biology and Gene Expression | Karpova, Tatiana | ZIC BC 011571 | Transcription factor mobility |
Laboratory of Receptor Biology and Gene Expression | Karpova, Tatiana | ZIC BC 011574 | LRBGE Optical Microscopy Core |
RNA Biology Laboratory | Kashlev, Mikhail | ZIA BC 010795 | Mechanisms of transcription pausing and fidelity in prokaryotes and eukaryotes |
HIV Dynamics and Replication Program | Kearney, Mary | ZIA BC 011681 | Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy |
HIV Dynamics and Replication Program | Kearney, Mary | ZIA BC 011697 | Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses |
HIV Dynamics and Replication Program | Kearney, Mary | ZIA BC 011698 | Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression |
HIV Dynamics and Replication Program | Kearney, Mary | ZIA BC 011699 | Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution |
HIV Dynamics and Replication Program | Kearney, Mary | ZIA BC 011995 | Assessment of SARS-Coronavirus-2 Levels and Genetics in Vivo |
Office of Science and Technology Resources | Kedei, Noemi | ZIC BC 011434 | Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section |
Mouse Cancer Genetics Program | Keller, Jonathan | ZIA BC 010001 | Molecular-Cellular Regulation of Hematopoietic Stem Cells |
Laboratory of Genitourinary Cancer Pathogenesis | Kelly Siebenlist, Kathleen | ZIA BC 011053 | TMPRSS2-ERG chromosomal translocations and prostate cancer |
Laboratory of Genitourinary Cancer Pathogenesis | Kelly Siebenlist, Kathleen | ZIA BC 011782 | Mechanisms of pathogenesis in patient derived organoid models of prostate cancer |
Laboratory of Genitourinary Cancer Pathogenesis | Kelly Siebenlist, Kathleen | ZIA BC 011919 | Identifying genetic vulnerabilities in neuroendocrine prostate cancer |
Laboratory of Genitourinary Cancer Pathogenesis | Kelly Siebenlist, Kathleen | ZIA BC 012111 | Biology of AR+ prostate cancer metastases and the role of the microenvironment |
Laboratory of Biochemistry and Molecular Biology | Kelly, Alexander | ZIA BC 011491 | Role of kinetochore proteins in chromosome segregation |
Office of the Director | Kelly, Michael | ZIC BC 012123 | Single Cell Analysis Facility |
Laboratory of Cell and Developmental Signaling | Kettenhofen, Christine | ZIC BC 011956 | Zebrafish core |
Cancer Innovation Laboratory | KewalRamani, Vineet | ZIA BC 010487 | The role of CPSF6 in HIV-1 infection |
Cancer Innovation Laboratory | KewalRamani, Vineet | ZIA BC 010488 | HIV-1 passage through the nuclear pore complex |
Cancer Innovation Laboratory | KewalRamani, Vineet | ZIA BC 011461 | SARS-CoV-2 and HIV-1 Interactions with C-Type Lectins |
Genetics Branch | Khan, Javed | ZIA BC 010806 | Developing Novel Therapies for High Risk Pediatric Cancers |
Genetics Branch | Khan, Javed | ZIA BC 010998 | Novel Mutations and Therapy Resistance Mechanisms in Pediatric Cancers |
Genetics Branch | Khan, Javed | ZIA BC 010999 | Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma |
Genetics Branch | Khan, Javed | ZIA BC 011002 | Bioinformatics: Systems Biology of Cancers |
Genetics Branch | Khan, Javed | ZIA SC 010366 | Predicting Response & Prognosis in Pediatric Cancers |
Laboratory of Molecular Biology | Khare, Anupama | ZIA BC 011819 | Mechanisms of multi-species bacterial interactions |
Laboratory of Molecular Biology | Khare, Anupama | ZIA BC 011821 | Evolution of antibiotic resistance |
Cancer Innovation Laboratory | Kimura, Shioko | ZIA BC 005522 | Thyroid regeneration and carcinogenesis |
Cancer Innovation Laboratory | Kimura, Shioko | ZIA BC 010449 | Role of Novel Cytokine-like Molecule Secretoglobin (SCGB) 3A2 in Lung |
Laboratory of Pathology | Kleiner, David | ZIC BC 010685 | Postmortem Pathology |
Surgery Branch | Klemen, Nicholas | ZIA BC 012121 | Retroviral genetic modification of PBLs to optimize expansion for cell therapy |
Molecular Imaging Branch | Kobayashi, Hisataka | ZIA BC 011512 | Activatable molecular cancer imaging probe |
Molecular Imaging Branch | Kobayashi, Hisataka | ZIA BC 011513 | Cancer-cell specific therapy: photo-immunotherapy |
Surgery Branch | Kochenderfer, James | ZIA BC 011415 | Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor |
Surgery Branch | Kochenderfer, James | ZIA BC 011417 | Improved Chimeric Antigen Receptor Therapies B-cell Malignancies |
Surgery Branch | Kochenderfer, James | ZIA BC 011439 | Development of Chimeric Antigen Receptors Targeting Multiple Myeloma |
Surgery Branch | Kochenderfer, James | ZIA BC 011660 | Development of fully-human anti-CD30 chimeric antigen receptors |
Cancer Data Science Laboratory | Kolmogorov, Mikhail | ZIA BC 012104 | Assembly-based methods to detect germline structural variation using long reads |
Cancer Data Science Laboratory | Kolmogorov, Mikhail | ZIA BC 012108 | Complex rearrangement detection in cancer genomes using long reads |
Cancer Data Science Laboratory | Kolmogorov, Mikhail | ZIA BC 012109 | Algorithms for strain-resolved metagenomics |
Laboratory of Cancer Biology and Genetics | Kraemer, Kenneth | ZIA BC 004517 | DNA Repair in Human Cancer-Prone Genetic Diseases |
Radiation Oncology Branch | Krauze, Andra | ZIA BC 012092 | Using artificial intelligence and MRI to address limitations in glioblastoma |
Radiation Oncology Branch | Krauze, Andra | ZIA BC 012093 | Proteogenomic characterization and biomarker discovery in glioblastoma |
Radiation Oncology Branch | Krauze, Andra | ZIA BC 012094 | Prognostic and predictive clinical and proteomic biomarker discovery in GBM |
Radiation Oncology Branch | Krauze, Andra | ZIA BC 012095 | Generating a multi-channel data framework for AI analysis in Radiation therapy |
Radiation Oncology Branch | Krauze, Andra | ZIA BC 012096 | Advancing clinically meaningful AI algorithms to improve oncologic outcomes |
Laboratory of Molecular Biology | Kreitman, Robert | ZIA BC 010301 | Development of Recombinant Toxins to Treat Hematologic Malignancies |
Laboratory of Molecular Biology | Kreitman, Robert | ZIA BC 011952 | Patterns of immune response in COVID-19 patients |
HIV and AIDS Malignancy Branch | Krug, Laurie | ZIA BC 011953 | Investigation of viral and host determinants of gammaherpesvirus pathogenesis |
HIV and AIDS Malignancy Branch | Krug, Laurie | ZIA BC 012014 | Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies |
Laboratory of Cancer Biology and Genetics | Kruhlak, Michael | ZIC BC 010858 | CCR Microscopy Core |
Laboratory of Genitourinary Cancer Pathogenesis | Lake, Ross | ZIC BC 010947 | Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility |
Genetics Branch | Lal, Ashish | ZIA BC 011646 | Role of long non-coding RNAs and RNA-binding proteins in p53 signaling |
Neuro-Oncology Branch | Larion, Mioara | ZIA BC 011707 | The effect of therapeutics on mutated IDH1 cell lines and mice tumor models |
Neuro-Oncology Branch | Larion, Mioara | ZIA BC 011708 | Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice |
Neuro-Oncology Branch | Larion, Mioara | ZIA BC 011709 | Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue |
Neuro-Oncology Branch | Larion, Mioara | ZIA BC 011710 | In vivo and in vitro metabolic flux analysis in preclinical mouse models |
Neuro-Oncology Branch | Larion, Mioara | ZIA BC 011711 | Develop RAMAN imaging to visualize metabolism in cell lines and tissue |
Developmental Therapeutics Branch | Larionov, Vladimir | ZIA BC 010413 | Human Artificial Chromosomes for Cancer Research and Functional Genomics |
Laboratory of Receptor Biology and Gene Expression | Larson, Daniel | ZIA BC 011383 | Transcription and Splicing Dynamics in Single Cells |
Center for Immuno-Oncology | Lassoued, Wiem | ZIC BC 012029 | Tumor Immune MicroEnvironment Facility |
Experimental Immunology Branch | Lazarevic, Vanja | ZIA BC 011431 | Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis |
Experimental Immunology Branch | Lazarevic, Vanja | ZIA BC 011765 | Transcriptional regulation of inflammatory and autoimmune responses |
Laboratory of Genome Integrity | Lazzerini Denchi, Eros | ZIA BC 011815 | Investigate the mechanism of action of the novel telomere length regulator TZAP |
Laboratory of Genome Integrity | Lazzerini Denchi, Eros | ZIA BC 011816 | Determine how telomere dysfunction impacts neuronal function |
Laboratory of Genome Integrity | Lazzerini Denchi, Eros | ZIA BC 012015 | Mechanism of end protection in stem cells |
Center for Structural Biology | Lea, Susan | ZIA BC 012043 | Structural biology of host-pathogen interactions |
Center for Structural Biology | Lea, Susan | ZIA BC 012069 | Eukaryotic Protein Maturation and Transport |
Center for Structural Biology | Lea, Susan | ZIA BC 012070 | Structural biology collaborations |
Laboratory of Cellular and Molecular Biology | Lebensohn, Andres | ZIA BC 011901 | New regulatory mechanisms of WNT signaling in development, stem cells and cancer |
Molecular Imaging Branch | Leblanc, Amy | ZIA BC 011692 | Comparative Oncology Program Laboratory |
Molecular Imaging Branch | Leblanc, Amy | ZIA BC 011696 | Comparative Brain Tumor Consortium |
Molecular Imaging Branch | Leblanc, Amy | ZIG BC 011689 | Comparative Oncology Trials Consortium |
Women's Malignancies Branch | Lee, Jung-Min | ZIA BC 011525 | Leveraging DNA damage repair pathways as therapeutic targets in womens cancers |
Cancer Innovation Laboratory | Lee, Kyung | ZIA BC 010681 | Development of inhibitors targeting Plk1 polo-box domain |
Cancer Innovation Laboratory | Lee, Kyung | ZIA BC 011518 | Molecular basis of centriole duplication |
Cancer Innovation Laboratory | Lee, Kyung | ZIA BC 012024 | Unraveling the molecular link between HIV/AIDS and cancer |
Laboratory of Cancer Biology and Genetics | Lee, Maxwell | ZIH BC 011703 | Integrated analyses of genetics, epigenetics, and gene expression |
Immune Deficiency and Cellular Therapy Program | Leko, Vid | ZIA BC 012116 | Targeting cancer neoantigens in patients with myeloid malignancies |
Laboratory of Pathology | Levens, David | ZIA BC 011011 | The genome-wide function of supercoiling and alternative DNA conformations |
Laboratory of Pathology | Levens, David | ZIA BC 011465 | c-Myc Function |
Laboratory of Pathology | Levens, David | ZIA SC 009144 | Mechanisms of transcription factor integration at the c-myc promoter |
Office of the Director | Levine, Jason | ZIH BC 011235 | Support of NCI CCR Clinical Research and Bioinformatics |
Cancer and Developmental Biology Laboratory | Lewandoski, Mark | ZIA BC 010338 | The Role of Fgf Signaling in Vertebrate Development |
Cancer and Developmental Biology Laboratory | Lewandoski, Mark | ZIA BC 010518 | Role of BMP and FGF signaling during limb development |
Cancer and Developmental Biology Laboratory | Lewandoski, Mark | ZIA BC 011321 | Identification and characterization of FGF target genes |
Laboratory of Biochemistry and Molecular Biology | Lichten, Michael | ZIA BC 005268 | Mechanism of Meiotic Recombination |
Molecular Imaging Branch | Lin, Frank | ZIA BC 011789 | Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma - pheochromocytoa |
Molecular Imaging Branch | Lin, Frank | ZIA BC 011825 | Th227-mesothelin and Zr89-mesothelin antibody conjugate in mesothelin tumors |
Molecular Imaging Branch | Lin, Frank | ZIA BC 011826 | Protection of Salivary Gland in PSMA-targeted radioligand therapy |
Molecular Imaging Branch | Lin, Frank | ZIA BC 011827 | Phase 1-2 study of Lu177-DOTATATE and olaparib in neuroendocrine tumors |
Molecular Imaging Branch | Lin, Frank | ZIA BC 011895 | Improving PSMA-based radioligand therapy via combination radioligand therapy |
Urologic Oncology Branch | Linehan, W. Marston | ZIA BC 011028 | Clinical Studies of the Molecular Genetic Basis of Kidney Cancer |
Urologic Oncology Branch | Linehan, W. Marston | ZIA BC 011038 | Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene |
Urologic Oncology Branch | Linehan, W. Marston | ZIA BC 011043 | Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene |
Urologic Oncology Branch | Linehan, W. Marston | ZID BC 011089 | Clinical Nursing and Data Management Core |
Urologic Oncology Branch | Linehan, W. Marston | ZID BC 011092 | Urologic Oncology Branch Consult Core |
Women's Malignancies Branch | Lipkowitz, Stanley | ZIA BC 010977 | Cbl Proteins as Regulators of Tyrosine Kinase Signaling |
Women's Malignancies Branch | Lipkowitz, Stanley | ZIA BC 011650 | Genomic characterization of breast cancer in high risk subsets of breast cancer |
Women's Malignancies Branch | Lipkowitz, Stanley | ZIA SC 007263 | Activating Cell Death Pathways in Breast Cancer Cells |
Laboratory of Immune Cell Biology | Liu, Zheng-Gang | ZIA BC 010783 | Inflammation, Macrophage Differentiation, and Cancer |
Laboratory of Immune Cell Biology | Liu, Zheng-Gang | ZIA SC 010376 | TNF Signaling, Cell Death and Cancer |
Laboratory of Genome Integrity | Livak, Ferenc | ZIC BC 011428 | CCR, LGI, Flow Cytometry Core |
Cancer Innovation Laboratory | Loncarek, Jadranka | ZIA BC 011459 | Control of centrosome biogenesis |
Laboratory of Cellular Oncology | Lowy, Douglas | ZIA BC 008905 | Tumor gene expression in vitro and in vivo |
Laboratory of Cellular Oncology | Lowy, Douglas | ZIA BC 010579 | Papillomavirus Virion Proteins and Vaccines |
Laboratory of Cancer Biology and Genetics | Luo, Ji | ZIA BC 011303 | Non-oncogene addiction in cancer cells |
Laboratory of Cancer Biology and Genetics | Luo, Ji | ZIA BC 011304 | Methods for mammalian genetic analysis |
Laboratory of Cancer Biology and Genetics | Luo, Ji | ZIA BC 011732 | Target discovery and combination therapy in KRAS mutant cancer |
Laboratory of Cancer Biology and Genetics | Luo, Ji | ZIA BC 011733 | Organoid models of KRAS mutant cancer |
Cancer Data Science Laboratory | Ma, Lichun | ZIA BC 012079 | Tumor heterogeneity in liver cancer |
Cancer Data Science Laboratory | Ma, Lichun | ZIA BC 012083 | Tumor evolution in response to treatment |
Developmental Therapeutics Branch | Machida, Yuichi | ZIA BC 012086 | DNA Replication and Repair |
Cancer and Developmental Biology Laboratory | Mackem, Susan | ZIA BC 011118 | Role of Shh in developmental patterning and growth of digit skeleton |
Cancer and Developmental Biology Laboratory | Mackem, Susan | ZIA BC 011119 | Hoxd and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis |
Cancer and Developmental Biology Laboratory | Mackem, Susan | ZIA BC 011120 | Genome-wide target analysis of Shh-activated transcription network in limb bud |
Cancer and Developmental Biology Laboratory | Mackem, Susan | ZIA BC 011319 | Role of FIR in limb morphogenesis |
Cancer and Developmental Biology Laboratory | Mackem, Susan | ZIA BC 011835 | Minimal Myc functional threshold for tumorigenesis |
Genitourinary Malignancies Branch | Madan, Ravi | ZIA BC 011896 | Evaluation of novel treatments in biochemically recurrent prostate |
Genitourinary Malignancies Branch | Madan, Ravi | ZIA BC 011897 | Evaluation of Immune-based Combinations in Prostate Cancer |
Genitourinary Malignancies Branch | Madan, Ravi | ZIA BC 012118 | Natural History of Biochemically Recurrent Prostate Cancer |
HIV Dynamics and Replication Program | Maldarelli, Frank | ZIA BC 010819 | HIV-1 Genetic Variation in Infected Individuals |
HIV Dynamics and Replication Program | Maldarelli, Frank | ZIA BC 011464 | Clinical Interventional Studies of HIV Reservoirs |
HIV Dynamics and Replication Program | Maldarelli, Frank | ZIA BC 011466 | HIV Persistence During Suppressive Antiretroviral Therapy |
Cancer Innovation Laboratory | Matsuo, Hiroshi | ZIC BC 011849 | Structural studies of biomolecules related to cancer and HIV-AIDS |
Experimental Immunology Branch | Mayer, Christian | ZIA BC 011975 | The role of apoptosis in B lymphocyte biology |
Experimental Immunology Branch | Mayer, Christian | ZIA BC 012038 | Antibody responses to viruses |
Pediatric Oncology Branch | McEachron, Troy | ZIA BC 012056 | Identification of immune evasion mechanisms in the osteosarcoma microenvironment |
Vaccine Branch | McKinnon, Katherine | ZIC BC 010936 | CCR Vaccine Branch FACS Core |
Cancer Innovation Laboratory | McVicar, Daniel | ZIA BC 010300 | Immunometabolism in Cancer and Inflammation |
Chemical Biology Laboratory | Meier, Jordan | ZIA BC 011488 | Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface |
Genetics Branch | Meltzer, Paul | ZIA BC 010759 | Functional Genomics of Sarcoma |
Genetics Branch | Meltzer, Paul | ZIA BC 011091 | Cancer Genomics Technology Development |
Genetics Branch | Meltzer, Paul | ZIA BC 011328 | Characterization of the Osteosarcoma Genome |
Laboratory of Pathology | Merino, Maria | ZIA BC 010696 | Study of Hereditary Renal and Other Familial Syndromes |
Laboratory of Pathology | Merino, Maria | ZIA BC 011405 | microRNA Profiling in the Spectrum of Kidney Tumors |
Laboratory of Pathology | Merino, Maria | ZIA BC 011406 | miRNA profiling of prostate cancer in young and older male patients |
Laboratory of Pathology | Merino, Maria | ZIA BC 012016 | Immunotherapy of kidney cancer. Where do the T lymphocytes go in kidney cancer? |
Laboratory of Pathology | Merino, Maria | ZIE SC 000853 | Translational Surgical Pathology |
Laboratory of Cancer Biology and Genetics | Merlino, Glenn | ZIA BC 008756 | Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression |
Laboratory of Cancer Biology and Genetics | Merlino, Glenn | ZIA BC 011167 | Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response |
Laboratory of Pathology | Miettinen, Markku | ZIA BC 011427 | Immunohistochemical and genomic analysis of tumors |
Laboratory of Pathology | Miettinen, Markku | ZID BC 011291 | General Surgical Pathology |
Laboratory of Cellular and Molecular Biology | Mili, Stavroula | ZIA BC 011501 | Regulation and functional effects of localized RNAs |
Radiation Oncology Branch | Miller, Robert | ZIA BC 010516 | Gated Optical Detectors-Dose Guided Radiotherapy |
Radiation Oncology Branch | Miller, Robert | ZIA SC 006330 | Radiation Field Modeling and Computerized Treatment Planning |
Radiation Oncology Branch | Miller, Robert | ZID SC 006329 | Clinical Radiation Physics Service |
Laboratory of Receptor Biology and Gene Expression | Misteli, Tom | ZIA BC 010309 | Nuclear Architecture and Disease |
Office of the Director | Misteli, Tom | ZIC BC 011021 | Basic Research Support for the CCR |
Office of the Director | Misteli, Tom | ZIC BC 011933 | Office of Translational Resources |
Office of the Director | Misteli, Tom | ZID BC 011022 | Clinical Research Support for the CCR |
Office of the Director | Misteli, Tom | ZIJ BC 011133 | CCR Office of Training and Education |
Radiation Biology Branch | Mitchell, James | ZIA BC 010946 | Protection against Radiation-Induced Carcinogenesis |
Radiation Biology Branch | Mitchell, James | ZIA SC 006321 | Modulation of Therapeutic Response |
Radiation Biology Branch | Mitchell, James | ZIA SC 006387 | Nitroxides as Protectors Against Oxidative Stress |
HIV and AIDS Malignancy Branch | Mitsuya, Hiroaki | ZIA BC 011486 | Development of Novel Agents Active against Hepatitis B Virus |
HIV and AIDS Malignancy Branch | Mitsuya, Hiroaki | ZIA BC 012018 | Development of therapeutics for SARS-CoV-2 infection |
HIV and AIDS Malignancy Branch | Mitsuya, Hiroaki | ZIA SC 006738 | Development of Antiviral Therapy of HIV-1 Infection |
Laboratory of Cancer Biology and Genetics | Mock, Beverly | ZIA BC 010008 | The Genetics of Susceptibility to Mouse Plasma Cell Tumors |
Laboratory of Cancer Biology and Genetics | Mock, Beverly | ZIA BC 011064 | A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1 |
Laboratory of Cancer Biology and Genetics | Mock, Beverly | ZIA BC 011065 | Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors) |
Laboratory of Cell and Developmental Signaling | Morrison, Deborah | ZIA BC 010329 | Regulation of Ras-Dependent Signal Transduction Pathways |
Laboratory of Cell and Developmental Signaling | Morrison, Deborah | ZIA BC 011107 | Role of Protein Scaffolds in RTK-Ras-dependent Signal Transduction |
Mouse Cancer Genetics Program | Muegge, Kathrin | ZIA BC 010014 | Epigenetic control during embryogenesis |
Lymphoid Malignancies Branch | Muppidi, Jagan | ZIA BC 011772 | The role of Galpha13 signaling in suppression of lymphoma |
Laboratory of Cancer Biology and Genetics | Murgai, Meera | ZIA BC 012006 | Perivascular plasticity in metastatic microenvironments |
Developmental Therapeutics Branch | Neckers, Jane | ZIC SC 006743 | Signal Transduction Events and the Regulation of Cell Growth |
Urologic Oncology Branch | Neckers, Leonard | ZIA BC 010683 | Role of FH loss in development of HLRCC heriditary kidney cancer |
Urologic Oncology Branch | Neckers, Leonard | ZIA BC 011032 | Post-translational modifications of Hsp90 |
Urologic Oncology Branch | Neckers, Leonard | ZIA SC 010074 | HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction |
Pediatric Oncology Branch | Nellan, Anandani | ZIA BC 012059 | Study of CAR T cells and mechanisms of resistance in pediatric brain tumors |
Lymphoid Malignancies Branch | Ng, Samuel | ZIA BC 012122 | Targeting exploitable vulnerabilities in T-cell Lymphoma |
Pediatric Oncology Branch | Nguyen, Hong Ha Rosa | ZIA BC 012066 | Development of new therapies for neuroblastoma |
Chemical Biology Laboratory | Nicklaus, Marc | ZIA BC 010524 | HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development |
Chemical Biology Laboratory | Nicklaus, Marc | ZIA BC 010832 | Fundamentals of Ligand-Protein Interactions |
Chemical Biology Laboratory | Nicklaus, Marc | ZIA BC 011666 | Synthetically Accessible Virtual Inventory (SAVI) |
Chemical Biology Laboratory | Nicklaus, Marc | ZIA BC 011785 | Better Understanding and Handling of Tautomerism |
Chemical Biology Laboratory | Nicklaus, Marc | ZIC BC 010517 | Large Databases of Small Molecules - Drug Development Tool and Public Resource |
Chemical Biology Laboratory | Nicklaus, Marc | ZIC BC 010639 | In Silico Screening for Cancer Targets |
Surgical Oncology Program | Nilubol, Naris | ZIA BC 011286 | Therapeutic targets and novel anticancer agents for endocrine cancers |
Laboratory of Genome Integrity | Nussenzweig, Andre | ZIA BC 010283 | DNA repair |
Laboratory of Genome Integrity | Nussenzweig, Andre | ZIA BC 010959 | Relationship between DNA damage detection and signaling |
Cancer Innovation Laboratory | Nussinov, Ruth | ZIA BC 010440 | Protein Structure, Stability, and Amyloid Formation |
Cancer Innovation Laboratory | Nussinov, Ruth | ZIA BC 010441 | Biomolecular Recognition and Binding Mechanisms |
Cancer Innovation Laboratory | Nussinov, Ruth | ZIA BC 010442 | Method Development: Efficient Computer Vision Based Algorithms |
Laboratory of Integrative Cancer Immunology | O'Huigin, Colm | ZIC BC 011237 | LICI Microbiome and Genetics Core |
Molecular Targets Program | O'Keefe, Barry | ZIA BC 011471 | Cell-free assay technologies for the identification of active compounds |
Molecular Targets Program | O'Keefe, Barry | ZIA BC 011472 | Isolation of bioactive proteins from natural product extracts |
Office of the Director | O'Keefe, Barry | ZIA BC 011854 | NCI Program for Natural Products Discovery - Cures |
Molecular Targets Program | O'Keefe, Barry | ZIA BC 011904 | Assay development and screening for molecular targets and discovery |
Center for Structural Biology | O'Reilly, Francis | ZIA BC 012113 | Discovery of novel protein complexes across human gut bacteria |
Center for Structural Biology | O'Reilly, Francis | ZIA BC 012114 | The topology of protein-protein interactions in situ in eukaryotic cells |
Laboratory of Receptor Biology and Gene Expression | Oberdoerffer, Shalini | ZIA BC 011293 | Cytidine modifications in mRNA processing and function |
Cancer Innovation Laboratory | Oppenheim, Joost | ZIA BC 009369 | Studies of Receptor Interactions and Effects of Alarmins |
Cancer Innovation Laboratory | Oppenheim, Joost | ZIA BC 010707 | Role of T Regulatory Cell Suppression in Autoimmunity and Cancer |
Immune Deficiency and Cellular Therapy Program | Pai, Sung-Yun | ZIA BC 012039 | Pathobiology and treatment of patients with severe combined immunodeficiency |
Immune Deficiency and Cellular Therapy Program | Pai, Sung-Yun | ZIA BC 012040 | Pathobiology and treatment of patients with inborn errors of immunity |
Immune Deficiency and Cellular Therapy Program | Pai, Sung-Yun | ZID BC 012026 | ID-CTP Clinical Core |
Center for Immuno-Oncology | Palena, Claudia | ZIC BC 010937 | Novel Targets for Immunotherapy |
Laboratory of Cellular and Molecular Biology | Pallikkuth, Sandeep | ZIC BC 010978 | Confocal Core for the Laboratory of Cellular and Molecular Biology |
Experimental Immunology Branch | Park, Jung-Hyun | ZIA BC 011214 | Post-Transcriptional Regulation of Interleukin-7 Receptor Expression |
Experimental Immunology Branch | Park, Jung-Hyun | ZIA BC 011215 | Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules |
Surgery Branch | Parkhurst, Maria | ZIC BC 011030 | The Antigen Targeting Core |
Laboratory of Molecular Biology | Pastan, Ira | ZIA BC 008753 | Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies |
Laboratory of Molecular Biology | Pastan, Ira | ZIA BC 010020 | Clinical Trials with Immunotoxins |
Laboratory of Molecular Biology | Pastan, Ira | ZIA BC 010298 | Growth Regulation Section |
Laboratory of Molecular Biology | Pastan, Ira | ZIA BC 012074 | CAR-T Therapy of Mesothelin Expressing Cancers |
HIV Dynamics and Replication Program | Pathak, Vinay | ZIA BC 010595 | Structure and Function of Vif and APOBEC3 (A3) Proteins |
HIV Dynamics and Replication Program | Pathak, Vinay | ZIA BC 011436 | Viral Replication and Interactions with Host Factors |
Vaccine Branch | Pavlakis, George | ZIA BC 010749 | Immunotherapeutic Approaches for AIDS |
Vaccine Branch | Pavlakis, George | ZIA BC 010750 | Heterodimeric IL-15 in Cancer Immunotherapy |
Vaccine Branch | Pavlakis, George | ZIA BC 011939 | COVID-19 vaccine development |
Immune Deficiency and Cellular Therapy Program | Pavletic, Steven | ZIA BC 011743 | NIH Chronic GVHD Study Group |
Immune Deficiency and Cellular Therapy Program | Pavletic, Steven | ZIA BC 012017 | NIH Myeloid Malignancy Program |
Laboratory of Receptor Biology and Gene Expression | Pegoraro, Gianluca | ZIC BC 011567 | HiTIF Microscopy Core Facility |
Urologic Oncology Branch | Pinto, Peter | ZIA BC 011081 | Prostate Section |
Urologic Oncology Branch | Pinto, Peter | ZIE BC 011023 | Clinical Fellowship Training Program |
Developmental Therapeutics Branch | Pommier, Yves | ZIA BC 006150 | DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs |
Developmental Therapeutics Branch | Pommier, Yves | ZIA BC 006161 | DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs |
Developmental Therapeutics Branch | Pommier, Yves | ZIA BC 011746 | Development Therapeutics Branch Clinical Trials |
Developmental Therapeutics Branch | Pommier, Yves | ZIA BC 011948 | TOP3B as host factor and drug target |
Thoracic and GI Malignancies Branch | Porat-Shliom, Natalie | ZIA BC 011828 | Hepatic mitochondria organization and functions |
Laboratory of Pathology | Pratt, Drew | ZIA BC 012117 | DNA methylation-based machine classification of cancer |
Cancer Data Science Laboratory | Rajagopal, Padma | ZIA BC 012057 | Leveraging RNA and synthetic lethality in germline BRCA-mut breast cancer |
Cancer Data Science Laboratory | Rajagopal, Padma | ZIA BC 012058 | Identifying Treatment Options using RNA-Based Synthetic Lethality and Rescue |
Cancer Data Science Laboratory | Rajagopal, Padma | ZIA BC 012112 | Germline-Somatic Interactions and Association with Treatment Response in Cancer |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 011900 | Pilot Study of Avelumab in Thymic Epithelial Tumors |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 011902 | Anetumab in Thymic Carcinoma |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 011905 | Anti-PD-L1-TGFb antibody (M7824) in advanced non-small cell lung cancer |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 011906 | CV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 011907 | Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 012001 | Phase II Trial of Bintrafusp Alfa in Subjects with Thymoma and Thymic Carcinoma |
Thoracic and GI Malignancies Branch | Rajan, Arun | ZIA BC 012106 | A Phase II Trial of PT-112 in Subjects with Thymoma and Thymic Carcinoma |
Office of the Clinical Director | Rajan, Arun | ZID BC 011543 | Medical Oncology Service Clinical Core |
Office of the Clinical Director | Rajan, Arun | ZID BC 011683 | Medical Oncology HIV-AIDS Clinical Research |
Laboratory of Molecular Biology | Ramamurthi, Kumaran | ZIA BC 011211 | Subcellular protein localization in B. subtilis |
HIV and AIDS Malignancy Branch | Ramaswami, Ramya | ZIA BC 011954 | Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease |
Laboratory of Cellular and Molecular Biology | Randazzo, Paul | ZIA BC 007365 | Regulation of ADP-ribosylation factor |
Pediatric Oncology Branch | Reilly, Karlyne | ZIA BC 011754 | Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1 |
HIV Dynamics and Replication Program | Rein, Alan | ZIA BC 010511 | Retrovirus Assembly and Maturation |
HIV Dynamics and Replication Program | Rein, Alan | ZIA BC 010512 | Interactions of Retroviral Proteins with Nucleic Acids |
HIV Dynamics and Replication Program | Rein, Alan | ZIA BC 011325 | Retrovirus Biology |
HIV Dynamics and Replication Program | Rein, Alan | ZIA BC 011991 | Actions of Restriction Factors on Coronaviruses |
Developmental Therapeutics Branch | Reinhold, William | ZIC BC 011475 | Genomics and Bioinformatics Group web site development and maintenance |
Developmental Therapeutics Branch | Reinhold, William | ZIC BC 011497 | RNA data development of cancer cell lines and patients |
Developmental Therapeutics Branch | Reinhold, William | ZIC BC 011509 | Comparison of molecular factors to drug activities |
Developmental Therapeutics Branch | Reinhold, William | ZIC BC 011820 | DNA data development for cancer cell lines and patients |
Genetics Branch | Ried, Thomas | ZIA BC 010833 | Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy |
Genetics Branch | Ried, Thomas | ZIA BC 010834 | Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer |
Genetics Branch | Ried, Thomas | ZIA BC 010837 | Disease prognostication and treatment response in rectal cancer patients |
Genetics Branch | Ried, Thomas | ZIA BC 012061 | Prediction of Therapy Response in Colorectal Cancer |
Surgery Branch | Robbins, Paul | ZIC BC 010948 | DNA Sequencing and FACS Core Facilities |
Laboratory of Pathology | Roberts, David | ZIA SC 009172 | Cellular Interactions with Thrombospondin |
Laboratory of Pathology | Roberts, David | ZIA SC 009174 | Roles of CD47 Signaling in Tumor Immunology |
Experimental Immunology Branch | Roche, Paul | ZIA BC 009404 | Regulation of MHC Class II Trafficking in Antigen Presenting Cells |
Experimental Immunology Branch | Roche, Paul | ZIA BC 011035 | Regulation of Exocytosis from Immune Cells |
Experimental Immunology Branch | Roche, Paul | ZIA BC 011687 | Dysregulation of Antigen Presenting Cell Function in Cancer |
Developmental Therapeutics Branch | Roper, Nitin | ZIA BC 011989 | Epigenetic and immunologic aspects of neuroendocrine cancers |
Developmental Therapeutics Branch | Roper, Nitin | ZIA BC 012053 | Developing ACC patient-derived organoids to identify therapeutic vulnerabilities |
Lymphoid Malignancies Branch | Roschewski, Mark | ZIA BC 011914 | Molecular Biology of Lymphoma |
Lymphoid Malignancies Branch | Roschewski, Mark | ZIA BC 011916 | Pathway inhibitors in Lymphomas |
Surgery Branch | Rosenberg, Steven | ZIA BC 010984 | Adoptive Cell Transfer Immunotherapy of Cancer |
Surgery Branch | Rosenberg, Steven | ZIA BC 010985 | Gene therapy of cancer |
OCD-OD Admin | Royce, Cheryl | ZID BC 010882 | Center for Cancer Research Clinical Trials Support |
OCD-OD Admin | Royce, Cheryl | ZID BC 010987 | Center for Cancer Research Patient Travel |
OCD-OD Admin | Royce, Cheryl | ZID BC 011716 | CCR Research Nursing |
Pediatric Oncology Branch | Rudloff, Udo | ZIA BC 011267 | Preclinical drug development in pancreatic cancer |
Laboratory of Genome Integrity | Ruiz Macias, Sergio | ZIA BC 011808 | Role of ETS-Transcription Factors in Regulating Cell Fate |
Laboratory of Genome Integrity | Ruiz Macias, Sergio | ZIA BC 011809 | Identification of molecular pathways regulating quiescence in pluripotent cells |
Laboratory of Genome Integrity | Ruiz Macias, Sergio | ZIA BC 011813 | Molecular Determinants of Totipotency |
Cancer Data Science Laboratory | Ruppin, Eytan | ZIA BC 011802 | Discovery of genetic interactions in cancer |
Cancer Data Science Laboratory | Ruppin, Eytan | ZIA BC 011803 | Cancer immunotherapy |
Cancer Data Science Laboratory | Ruppin, Eytan | ZIA BC 012000 | Discovering Affective Drug Combinations for Treating Covid-19 |
Surgical Oncology Program | Sadowski, Samira | ZIA BC 011899 | Targeted Therapy in Neuroendocrine Cancer |
Cancer Data Science Laboratory | Sahinalp, Suleyman Cenk | ZIA BC 011987 | Tumor evolution and intratumor heterogeneity |
Cancer Data Science Laboratory | Sahinalp, Suleyman Cenk | ZIA BC 011988 | Privacy Preserving Genome Analysis |
Thoracic and GI Malignancies Branch | Saloura, Vassiliki | ZIA BC 011831 | The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck |
Thoracic and GI Malignancies Branch | Saloura, Vassiliki | ZIA BC 011859 | IMRRT for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma |
Thoracic and GI Malignancies Branch | Saloura, Vassiliki | ZIA BC 012089 | Neoadjuvant Photoimmunotherapy in Head and Neck Cancer |
Laboratory of Cellular and Molecular Biology | Samelson, Lawrence | ZIA BC 010304 | Biochemical Basis of T Cell Activation |
Laboratory of Cellular Oncology | Schiller, John | ZIA BC 009052 | Understanding Papillomavirus Virion Proteins and Vaccines |
Center for Immuno-Oncology | Schlom, Jeffrey | ZIA BC 010425 | Strategies for Cancer Immunotherapy Clinical Trials |
Center for Immuno-Oncology | Schlom, Jeffrey | ZIA BC 010598 | Human Immune Responses to Tumor Antigens for Cancer Immunotherapy |
Center for Immuno-Oncology | Schlom, Jeffrey | ZIA BC 010944 | Strategies for Cancer Immunotherapy Development: Preclinical Studies |
Chemical Biology Laboratory | Schneekloth, John | ZIA BC 011585 | Identification of Nucleic Acid Binding Small Molecules |
Chemical Biology Laboratory | Schneekloth, John | ZIA BC 011970 | Targeting Functional RNA Elements in the SARS-CoV-2 Genome |
Chemical Biology Laboratory | Schneider, Joel | ZIA BC 011313 | Design and Utility of Novel Proteinaceous Biomaterials |
Chemical Biology Laboratory | Schneider, Joel | ZIA BC 011314 | Development of antibacterial agents and materials |
Chemical Biology Laboratory | Schneider, Joel | ZIC BC 011515 | Chemical Synthesis Group |
Chemical Biology Laboratory | Schneider, Joel | ZIC BC 011958 | Medicinal Chemistry Core |
Chemical Biology Laboratory | Schnermann, Martin | ZIA BC 011506 | New Synthetic Approaches to Small Molecules for Imaging |
Chemical Biology Laboratory | Schnermann, Martin | ZIA BC 011564 | Applying Optical Approaches to the Drug Delivery Problem |
Chemical Biology Laboratory | Schroeder, Christina | ZIA BC 011960 | Discovery and characterisation of recifin |
Chemical Biology Laboratory | Schroeder, Christina | ZIA BC 011998 | Synthesis and Development of Trefoil Factor Peptides |
Chemical Biology Laboratory | Schroeder, Christina | ZIA BC 012002 | Development of imaging probes for surgery |
Chemical Biology Laboratory | Schroeder, Christina | ZIA BC 012003 | Discovery and development of voltage-gated sodium channel inhibitors |
Chemical Biology Laboratory | Schroeder, Christina | ZIA BC 012004 | Discovery of bioactive peptides targeting ion channels upregulated in cancer |
Thoracic Surgery Branch | Schrump, David | ZIA BC 011115 | Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies |
Thoracic Surgery Branch | Schrump, David | ZIA BC 011418 | Modulating Cancer Stem Cell Signaling in Thoracic Malignancies |
Thoracic Surgery Branch | Schrump, David | ZIA SC 010093 | Epigenetic Therapy for Thoracic Malignancies |
Thoracic Surgery Branch | Schrump, David | ZID BC 011911 | Thoracic Surgery Consultative Services |
Pediatric Oncology Branch | Shah, Nirali | ZIA BC 011823 | Development of Novel Therapies for Acute Lymphoblastic Leukemia |
Pediatric Oncology Branch | Shah, Nirali | ZIA BC 011927 | Clinical Development of Immunotherapies for Rare Hematologic Maligancies |
Mouse Cancer Genetics Program | Sharan, Shyam | ZIA BC 010387 | Functional Analysis of Breast Cancer Susceptibility Genes in Mice |
Mouse Cancer Genetics Program | Sharan, Shyam | ZIA BC 011181 | Functional Analysis of Human Breast Cancer Susceptibility Gene Variants |
Mouse Cancer Genetics Program | Sharan, Shyam | ZIA BC 011311 | Identification of genetic interactors of Brca2 |
Center for Advanced Preclinical Research | Sharan, Shyam | ZIA BC 011736 | Preclinical Development of Therapeutics in Murine Models of Lung Cancer |
Center for Advanced Preclinical Research | Sharan, Shyam | ZIA BC 011737 | Therapeutic evaluation in ovarian and breast cancer GEM-GDA models |
Center for Advanced Preclinical Research | Sharan, Shyam | ZIA BC 011738 | Preclinical GEM and GDA Models of Primary and Metastatic Melanoma |
Center for Advanced Preclinical Research | Sharan, Shyam | ZIA BC 011739 | Development and Preclinical Applications of Pancreatic Adenocarcinoma Models |
Center for Advanced Preclinical Research | Sharan, Shyam | ZIA BC 011848 | Preclinical Modelling and Therapeutic Development for Other Cancer Indications |
Center for Advanced Preclinical Research | Sharan, Shyam | ZIG BC 011735 | Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure |
Experimental Immunology Branch | Sharrow, Susan | ZIC BC 009255 | Application of Flow Cytometry to Cell Biology |
Pediatric Oncology Branch | Shern, John | ZIA BC 011722 | Genomic characterization and development of therapies for pediatric sarcoma |
Pediatric Oncology Branch | Shern, John | ZIA BC 011734 | Genomic dissection of tumor heterogeneity and progression |
OCD-OD Admin | Shorer, Shy | ZID BC 011875 | Office of Sponsor and Regulatory Oversight |
Laboratory of Cancer Biology and Genetics | Simpson, R. Mark | ZIC BC 010953 | Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers |
Laboratory of Cancer Biology and Genetics | Simpson, R. Mark | ZIG BC 010931 | Comparative Biomedical Scientist Training Program |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 009273 | T Cell Differentiation and Repertoire Selection |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011106 | Specification of T cell function during development |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011111 | Cytokine signaling in developing thymocytes and T cells |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011112 | Development and function of regulatory T cells |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011113 | T cell survival |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011114 | Role of microRNAs in T cell development |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011116 | MHC-independent T cells |
Experimental Immunology Branch | Singer, Alfred | ZIA BC 011117 | T cell receptor regulation of cytokine signaling |
Experimental Immunology Branch | Singer, Dinah | ZIA BC 011381 | Brd4 is an atypical kinase that regulates transcription |
Experimental Immunology Branch | Singer, Dinah | ZIA BC 011688 | In vivo function of BRD4 |
Experimental Immunology Branch | Singer, Dinah | ZIA BC 011882 | Interactions Between MYC and BRD4 Result in Their Reciprocal Regulation |
Experimental Immunology Branch | Singer, Dinah | ZIA BC 011883 | BRD4 Contributes to the Regulation of Alternative Splicing |
Experimental Immunology Branch | Singer, Dinah | ZIA BC 012027 | The Role of the Cellular Transcription Factor, TAF7, in HIV Biology |
Experimental Immunology Branch | Singer, Dinah | ZIA BC 012042 | Transgenerational Epigenetic Inheritance Mediated by a Core Promoter Element |
Experimental Immunology Branch | Singer, Dinah | ZIA SC 010375 | TAF7: A Check-point Regulator in Transcription Initiation and Translation |
Radiation Oncology Branch | Smart, DeeDee | ZIA BC 011222 | CNS sirtuins in radiation-induced vascular permeability and neurodegeneration |
Radiation Oncology Branch | Smart, DeeDee | ZIA BC 011333 | Neuropsychological outcome measures in patients receiving whole brain radiation |
Radiation Oncology Branch | Smart, DeeDee | ZIA BC 011790 | Metabolic imaging of the effects of brain radiotherapy |
Laboratory of Genitourinary Cancer Pathogenesis | Sowalsky, Adam | ZIA BC 011679 | Molecular alterations driving the development of primary prostate cancers |
Laboratory of Genitourinary Cancer Pathogenesis | Sowalsky, Adam | ZIA BC 011680 | Detection of prostate cancer using circulating tumor DNA |
Laboratory of Genitourinary Cancer Pathogenesis | Sowalsky, Adam | ZIA BC 011838 | Mechanisms of resistance to treatment in aggressive prostate cancers |
Urologic Oncology Branch | Srinivasan, Ramaprasad | ZIA BC 011648 | Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC |
Urologic Oncology Branch | Srinivasan, Ramaprasad | ZIA BC 011920 | Novel Approaches to Targeting Cancers Associated with VHL Mutations |
Mouse Cancer Genetics Program | St. Croix, Brad | ZIA BC 010484 | Functional Analysis of TEM5 and TEM8 |
Mouse Cancer Genetics Program | St. Croix, Brad | ZIA BC 010578 | Targeting TEMs in Preclinical Tumor Models |
Mouse Cancer Genetics Program | St. Croix, Brad | ZIA BC 010736 | Unraveling the function of CD276 |
Laboratory of Cellular Oncology | Starrett, Gabriel | ZIA BC 011894 | Biology of Virus-associated Cancers |
Lymphoid Malignancies Branch | Staudt, Louis | ZIA BC 011006 | Molecular diagnosis and outcome prediction in lymphoma |
Lymphoid Malignancies Branch | Staudt, Louis | ZIA BC 011007 | Functional genomic screens for molecular targets in cancer |
Lymphoid Malignancies Branch | Staudt, Louis | ZIA BC 011008 | Oncogenic mechanisms and molecular targets in lymphoma |
Lymphoid Malignancies Branch | Staudt, Louis | ZIA BC 011780 | Clinical development of mechanism-based lymphoma therapies |
Women's Malignancies Branch | Steeg, Patricia | ZIA BC 010538 | Molecular Analysis of Breast Cancer Metastasis to the Brain |
Women's Malignancies Branch | Steeg, Patricia | ZIA BC 011718 | Breast cancer aggressiveness in young patients |
Women's Malignancies Branch | Steeg, Patricia | ZIA SC 000892 | Molecular Biology of the Metastatic Phenotype |
OCD-OD Admin | Steinberg, Seth | ZID SC 007202 | Biostatistics and Data Management Section |
Laboratory of Cell and Developmental Signaling | Sterneck, Esta | ZIA BC 010307 | Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells |
Laboratory of Pathology | Stetler-Stevenson, William | ZIA BC 011204 | Development of TIMP-2 derivatives or strategies as biologic therapies for cancer |
Laboratory of Pathology | Stetler-Stevenson, William | ZIA SC 009179 | The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis |
Radiation Oncology Branch | Stracker, Travis | ZIA BC 012010 | Tousled like kinase signaling in cancer |
Radiation Oncology Branch | Stracker, Travis | ZIA BC 012012 | Identification of radiosensitizers for prostate cancer |
Center for Immuno-Oncology | Strauss, Julius | ZIA BC 011547 | Cancer Immunotherapy Clinical Trials |
Experimental Immunology Branch | Takahama, Yousuke | ZIA BC 011806 | Thymus biology |
Laboratory of Genitourinary Cancer Pathogenesis | Takeda, David | ZIA BC 011965 | Mechanism of epigenetic activation during disease progression |
Laboratory of Genitourinary Cancer Pathogenesis | Takeda, David | ZIA BC 011973 | Identification of epigenetic drivers of advanced prostate cancer |
Laboratory of Cell Biology | Tanner, Kandice | ZIA BC 011433 | The Role of Coherent Rotation in Adult Tissue Remodeling |
Laboratory of Cell Biology | Tanner, Kandice | ZIA BC 011524 | Mechanical regulation of the microenvironmental niche in skin tumorigenesis |
Laboratory of Cell Biology | Tanner, Kandice | ZIA BC 011559 | The role of the tumor biofilm in determining tissue tropism |
Laboratory of Cell Biology | Tanner, Kandice | ZIA BC 011903 | Synthetic bacteria as a targeted delivery system for small molecule therapeutics |
Center for Structural Biology | Tarasov, Sergey | ZIC BC 010965 | CCR Biophysics Resource Core |
Cancer Innovation Laboratory | Tarasova, Nadya | ZIA BC 011306 | Inhibitors of protein-protein interactions |
Cancer Innovation Laboratory | Tarasova, Nadya | ZIA BC 011307 | Self-assembling protoviral nanoparticles |
Cancer Innovation Laboratory | Tarasova, Nadya | ZIA BC 011944 | Development of COVID-19 cell entry inhibitors |
Pediatric Oncology Branch | Taylor, Naomi | ZIA BC 011923 | Metabolic regulation of T cell effector function and anti-tumor immunotherapy |
Pediatric Oncology Branch | Taylor, Naomi | ZIA BC 011924 | Reprogramming hematopoietic stem cell (HSC) differentiation via metabolic condit |
Laboratory of Pathology | Telford, William | ZIC BC 011138 | FACS Core Facility |
Laboratory of Pathology | Telford, William | ZIC BC 011139 | Application of novel laser technology for flow cytometric analysis |
Neuro-Oncology Branch | Terabe, Masaki | ZIA BC 011877 | Immunological Analysis of Brain Cancer |
Mouse Cancer Genetics Program | Tessarollo, Lino | ZIA BC 010390 | Role of Neurotrophins in the Development of the Mammalian Nervous System |
Mouse Cancer Genetics Program | Tessarollo, Lino | ZIA BC 010391 | Role of Trk Receptors in the Development and Function of Non-neuronal Structures |
Mouse Cancer Genetics Program | Tessarollo, Lino | ZIC BC 011265 | Gene Targeting Facility |
Pediatric Oncology Branch | Thiele, Carol | ZIA BC 010788 | Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma |
Pediatric Oncology Branch | Thiele, Carol | ZIA BC 010789 | Pathophysiologic Consequences of Survival Signaling in Neuroblastoma |
Pediatric Oncology Branch | Thiele, Carol | ZIA BC 012046 | Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation |
Developmental Therapeutics Branch | Thomas, Anish | ZIA BC 011793 | Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies |
Radiation Oncology Branch | Tofilon, Philip | ZIA BC 011372 | Microenvironmental regulation of glioblastoma radiosensitivity |
Radiation Oncology Branch | Tofilon, Philip | ZIA BC 011373 | Radiation-induced translational control of gene expression |
Laboratory of Cellular Oncology | Tosato, Giovanna | ZIA BC 010782 | Study of the Roles of SDF1 and CXCR4 in Hematopoiesis |
Laboratory of Cellular Oncology | Tosato, Giovanna | ZIA SC 010355 | Angiogenesis and Tumor Growth |
Laboratory of Cellular Oncology | Tosato, Giovanna | ZIA SC 010356 | A Role for KSHV in the Pathogenesis of Malignancies |
Laboratory of Integrative Cancer Immunology | Trinchieri, Giorgio | ZIA BC 010793 | Role of inflammation, innate resistance, and immunity in carcinogenesis |
Laboratory of Integrative Cancer Immunology | Trinchieri, Giorgio | ZIA BC 011152 | Regulation of human dendritic cell activation |
Laboratory of Integrative Cancer Immunology | Trinchieri, Giorgio | ZIA BC 011153 | Role of microbiome in cancer and inflammation |
Molecular Imaging Branch | Turkbey, Ismail | ZIA BC 012062 | Imaging, image guided biopsy and treatment of prostate cancer |
Molecular Imaging Branch | Turkbey, Ismail | ZIH BC 012032 | CCR Artificial Intelligence Resource |
Center for Structural Biology | Valkov, Anna | ZIC BC 012081 | Protein Technology Core |
RNA Biology Laboratory | Valkov, Eugene | ZIA BC 011977 | Molecular Mechanisms of mRNA Regulation and Decay |
Laboratory of Biochemistry and Molecular Biology | Vidigal, Joana | ZIA BC 011810 | Canonical and non-canonical roles of Argonaute proteins in mammals |
Laboratory of Biochemistry and Molecular Biology | Vidigal, Joana | ZIA BC 011811 | CRISPR tools to dissect the coding and non-coding genome |
Urologic Oncology Branch | Vocke, Cathy | ZIC BC 011044 | Tissue Processing-Sequencing Facility |
Laboratory of Cancer Biology and Genetics | Wakefield, Lalage | ZIA BC 005785 | TGF-betas in breast cancer progression |
Laboratory of Cancer Biology and Genetics | Wakefield, Lalage | ZIA BC 010881 | Development of TGF-beta antagonists for cancer therapy |
Lymphoid Malignancies Branch | Waldmann, Thomas | ZIA SC 004002 | IL-2:IL-15 : implications for cancer therapy |
Lymphoid Malignancies Branch | Waldmann, Thomas | ZIB BC 010906 | Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy |
Center for Structural Biology | Walters, Kylie | ZIA BC 011490 | Ubiquitin signaling for protein degradation |
Center for Structural Biology | Walters, Kylie | ZIA BC 011627 | Mechanisms of function and targeting for complexes relevant to cancer biology |
Laboratory of Pathology | Wang, Hao-Wei | ZIC BC 011093 | Flow cytometric detection of malignant cells in body fluids |
Laboratory of Pathology | Wang, Hao-Wei | ZIC BC 011104 | Flow cytometric evaluation of biomarkers |
Laboratory of Pathology | Wang, Hao-Wei | ZIC SC 009372 | Flow cytometric analysis of benign and malignant tumors |
Cancer Innovation Laboratory | Wang, Ji Ming | ZIA BC 010015 | The Role of Cellular Receptors Involved in Inflammation and Tumor Progression |
Cancer Innovation Laboratory | Wang, Ji Ming | ZIA BC 010725 | Role of Formylpeptide Receptors in Host Defense |
Laboratory of Human Carcinogenesis | Wang, Xin Wei | ZIA BC 005793 | Roles of microbiota-mediated hepatocarcinogenesis |
Laboratory of Human Carcinogenesis | Wang, Xin Wei | ZIA BC 010313 | Molecular signatures for liver cancer diagnosis and treatment stratification |
Laboratory of Human Carcinogenesis | Wang, Xin Wei | ZIA BC 010876 | The role of cancer stem cells in liver cancer heterogeneity and subtypes |
Laboratory of Human Carcinogenesis | Wang, Xin Wei | ZIA BC 010877 | The identification of human hepatocellular carcinoma metastasis genes |
Laboratory of Human Carcinogenesis | Wang, Xin Wei | ZIA BC 011951 | Viral exposure signatures may define individuals vulnerable for COVID-19 |
Laboratory of Human Carcinogenesis | Wang, Xin Wei | ZIC BC 012048 | Identification of viral exposure signatures for early detection of liver cancer |
Center for Structural Biology | Wang, Yun-Xing | ZIA BC 010379 | Search for the Structural Basis of Biomacromolecular Function and Activity |
Center for Structural Biology | Wang, Yun-Xing | ZIA BC 011669 | NCI X-ray free electron laser (XFEL) initiative |
Center for Structural Biology | Wang, Yun-Xing | ZIC BC 011535 | SAXS Core |
Laboratory of Cellular and Molecular Biology | Weigert, Roberto | ZIA BC 011682 | Molecular mechanisms of membrane remodeling |
Laboratory of Cellular and Molecular Biology | Weigert, Roberto | ZIC BC 012030 | Intravital Microscopy Core |
Cancer Innovation Laboratory | Weissman, Allan | ZIA BC 009392 | Determining the Fate of Transmembrane Proteins |
Cancer Innovation Laboratory | Weissman, Allan | ZIA BC 010292 | Enzymes and Substrates of the Ubiquitin Conjugating System |
Laboratory of Cell and Developmental Signaling | Westlake, Christopher | ZIA BC 011398 | Regulation of Ciliogenesis and Ciliary-related signaling |
Developmental Therapeutics Branch | Weyemi, Urbain Sossou | ZIA BC 012071 | Dialogue between genomic instability and metabolism in diseases |
Laboratory of Molecular Biology | Wickner, Sue | ZIA BC 008710 | Molecular Chaperones and DNA Replication |
Office of the Director | Widemann, Brigitte | ZIA BC 011852 | MyPART: My Pediatric and Adult Rare Tumor Network - Cures |
Pediatric Oncology Branch | Widemann, Brigitte | ZIA SC 010354 | Therapies for patients with rare tumors and genetic tumor predisposition |
Office of the Director | Wiener, Lori | ZIA BC 011874 | Graft-Versus-Host Disease Symptom Management-Cures |
Lymphoid Malignancies Branch | Wilson, Wyndham | ZIA BC 011354 | Targeted treatment of B-cell Lymphoma |
Lymphoid Malignancies Branch | Wilson, Wyndham | ZIA SC 006741 | Therapeutic Strategies and Molecular Correlates in Aggressive B-cell Lymphomas |
Cancer Innovation Laboratory | Wink, David | ZIA BC 010898 | Redox Mechanism Process of Angiogenesis and Wound Healing |
Cancer Innovation Laboratory | Wink, David | ZIA BC 010899 | Inflammation and cancer treatment |
Cancer Innovation Laboratory | Wink, David | ZIA BC 011190 | Chemical Biology of Nitroxyl (HNO) |
Cancer Innovation Laboratory | Wink, David | ZIA SC 007281 | Nitric Oxide as a Modifier of Oxidative Stress |
Office of the Director | Winkler-Pickett, Robin | ZIC BC 011596 | CCR Dedicated Cores |
Cancer Innovation Laboratory | Winkler, Cheryl | ZIA BC 010022 | Genetics of Complex Diseases and Health Disparities |
Cancer Innovation Laboratory | Winkler, Cheryl | ZIA BC 010297 | Identification of Genetic Factors Associated with Infectious Diseases |
Experimental Immunology Branch | Wisniewski, Jan | ZIC BC 010915 | EIB Microscopy Core Facility |
Center for Structural Biology | Wlodawer, Alexander | ZIA BC 010348 | Protein Structure |
Center for Structural Biology | Wlodawer, Alexander | ZIA BC 011966 | Chimeric ACE2 peptide ligand for diagnostic assays of SARS-CoV-2 |
Laboratory of Pathology | Wloka, Kaska | ZIC BC 012115 | Establishing a clinical research flow cytometry core |
Cancer Innovation Laboratory | Wolf, Matthew | ZIA BC 012021 | Cancer Biomaterials Engineering |
RNA Biology Laboratory | Wolin, Sandra | ZIA BC 011757 | Biogenesis, Function and Turnover of Noncoding RNAs |
Office of the Director | Wood, Bradford | ZIA BC 011936 | Development of COVID-19 and Cancer Tools with Artificial Intelligence |
Office of the Director | Wood, Bradford | ZID BC 011242 | Center for Interventional Oncology |
Experimental Immunology Branch | Wu, Chuan | ZIA BC 011755 | The role of Foxo1 for intestinal epithelial cells during mucosal immune response |
Experimental Immunology Branch | Wu, Chuan | ZIA BC 011801 | CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity |
Experimental Immunology Branch | Wu, Chuan | ZIA BC 012034 | IL-33 promotes serotonin release from enterochromaffin cells |
RNA Biology Laboratory | Wu, Colin (Chih-Chien) | ZIA BC 012037 | Noncanonical functions of the ribosome in response to cellular stress |
Neuro-Oncology Branch | Wu, Jing | ZIA BC 011840 | Discovering novel therapies for glioma patients |
Neuro-Oncology Branch | Wu, Jing | ZIA BC 011841 | Understanding IDH mutant gliomas |
Laboratory of Pathology | Xi, Liqiang | ZIC BC 011079 | Molecular Diagnostics Core Laboratory |
Laboratory of Pathology | Xi, Liqiang | ZID BC 011792 | Development of FISH Molecular Diagnostics to support Clinical Trials at NCI |
Laboratory of Pathology | Xi, Liqiang | ZID BC 011959 | NCI COMPASS-Comprehensive Oncologic Molecular Pathology and Sequencing Service |
Laboratory of Cell Biology | Xia, Di | ZIA BC 010319 | Structural Basis of Biological Membrane Protein Functions and Drug Resistance |
Laboratory of Cell Biology | Xia, Di | ZIA BC 010600 | AAA Proteins, Their Functions and Related Diseases |
Laboratory of Cell Biology | Xia, Di | ZIA BC 011972 | Mechanism of Inhibition of Entry Inhibitors against SARS-CoVs |
Thoracic and GI Malignancies Branch | Xie, Changqing | ZIA BC 011888 | Cancer Stem Cells in Cholangiocarcinoma |
Cancer and Developmental Biology Laboratory | Yamaguchi, Terry | ZIA BC 010345 | The Role of Wnt Genes in Vertebrate Development and Cancer |
Neuro-Oncology Branch | Yang, Chun Zhang | ZIA BC 011684 | Chemo-sensitizing IDH1-mutated glioma by molecular targeting |
Neuro-Oncology Branch | Yang, Chun Zhang | ZIA BC 011761 | Nrf2-goverened metabolic reprogram in IDH1-mutated glioma |
Neuro-Oncology Branch | Yang, Chun Zhang | ZIA BC 011876 | Establish Preclinical Model for IDH-mutated Glioma |
Surgery Branch | Yang, James | ZIA BC 011337 | Generation of T-cell receptors recognizing antigens on non-melanoma tumors |
Surgery Branch | Yang, James | ZIA BC 011651 | Laboratory and Clinical studies on T-cells recognizing NSCLC |
Surgery Branch | Yang, James | ZIA BC 011843 | Identification and use of T-cell receptors recognizing common tumor mutations |
Laboratory of Cancer Biology and Genetics | Yang, Li | ZIA BC 011163 | Myeloid TGFbeta signaling in breast cancer metastasis |
Laboratory of Cancer Biology and Genetics | Yang, Li | ZIA BC 011165 | Roles of tumor suppressors (TSs) in metastatic progression |
HIV and AIDS Malignancy Branch | Yarchoan, Robert | ZIA BC 010885 | Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies |
HIV and AIDS Malignancy Branch | Yarchoan, Robert | ZIA BC 010888 | Clinical Trials of Patients with AIDS-Related Malignancies |
HIV and AIDS Malignancy Branch | Yarchoan, Robert | ZIA BC 011945 | Study of and development of antiviral drugs against SARS-CoV2 protease |
HIV and AIDS Malignancy Branch | Yarchoan, Robert | ZIA SC 006737 | Development of Preventive Strategies and Therapy for HIV Infection |
Laboratory of Cell and Developmental Signaling | Yohe, Marielle | ZIA BC 011804 | Dual Blockade of IGF1R and MEK synergistically inhibits pediatric cancers |
Laboratory of Cell and Developmental Signaling | Yohe, Marielle | ZIA BC 011869 | Advancing RAS and RASopathy Therapies |
Laboratory of Cell and Developmental Signaling | Yohe, Marielle | ZIA BC 011892 | Targeting RAS in Pediatric Cancer |
Laboratory of Cell and Developmental Signaling | Yohe, Marielle | ZIA BC 011993 | Regulation of differentiation and invasion in RMS by ASAP1 |
Chemical Biology Laboratory | Yoo, Euna | ZIA BC 011961 | Synthesis and characterization of covalent ligand library |
Chemical Biology Laboratory | Yoo, Euna | ZIA BC 011962 | Understanding functional roles and regulation of granzyme |
Chemical Biology Laboratory | Yoo, Euna | ZIA BC 011963 | Targeting ISG15 and USP18 |
Cancer Data Science Laboratory | Youkharibache, Philippe | ZIA BC 011990 | Structural basis of viral RBDs binding to cell receptors |
Cancer Data Science Laboratory | Youkharibache, Philippe | ZIA BC 011997 | CAR and Antibodies Structure-Activity Relationships and molecular architecture |
Cancer Data Science Laboratory | Youkharibache, Philippe | ZIH BC 012005 | Structural data science methods and software to study immunotherapeutic proteins |
Cancer Innovation Laboratory | Young, Howard | ZIA BC 009283 | Consequences of chronic Interferon-gamma expression on the host |
Lymphoid Malignancies Branch | Young, Ryan | ZIA BC 011999 | Identifying novel modes of oncogenic signaling in multiple myeloma |
Laboratory of Cancer Biology and Genetics | Yuspa, Stuart | ZIA BC 004504 | Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis |
Laboratory of Cancer Biology and Genetics | Yuspa, Stuart | ZIA BC 005445 | Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer |
OCD-OD Admin | Zeiger, Martha | ZIE BC 011992 | Training and Development of Outstanding Surgeon Scientists |
Center for Structural Biology | Zhang, Ping | ZIA BC 011744 | Mechanistic Analyses of kinase signaling complexes |
Laboratory of Cellular and Molecular Biology | Zhang, Ying | ZIA BC 010419 | Molecular Mechanisms of TGF-beta Signaling Pathway |
Laboratory of Cellular and Molecular Biology | Zhang, Ying | ZIA BC 011168 | Physiological and pathological functions of E3 ubiquitin ligases Smurfs |
Thoracic and GI Malignancies Branch | Zhao, Chen | ZIA BC 012008 | Study interactions between lung microbiota and immune cells in NSCLC |
Thoracic and GI Malignancies Branch | Zhao, Chen | ZIA BC 012011 | Investigate heterogeneous neutrophils in NSCLC |
HIV Dynamics and Replication Program | Zheng, Zhi-Ming | ZIA SC 010357 | Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses |
Neuro-Oncology Branch | Zhuang, Zhengping | ZIA BC 011773 | Hypoxia signaling in cancer development |
Laboratory of Cell Biology | Zhurkin, Victor | ZIA BC 010844 | DNA Folding in Chromatin at the Supra-nucleosome Level |
Laboratory of Cell Biology | Zhurkin, Victor | ZIA BC 010845 | p53-induced Regulation of Transcription in the Chromatin Context |
HIV and AIDS Malignancy Branch | Ziegelbauer, Joseph | ZIA BC 011176 | Functions of KSHV microRNAs and circular RNAs |
HIV and AIDS Malignancy Branch | Ziegelbauer, Joseph | ZIA BC 012047 | Virus host interactions in clinical samples |
Overview
Content Tools
ThemeBuilder